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 Phenotypic variation in multi-cellular organisms arises as a result complex 
gene regulation mechanisms. Modern development of high-through technology 
opens up the possibility of genome-wide interrogation of aspects of these 
mechanisms across molecular phenotypes. Multivariate statistical methods provide 
convenient frameworks for modeling and analyzing data obtained from high-
throughput experiments probing these complex aspects. This dissertation presents 
multivariate statistical methods to analyze data arising from two specific high-
throughput molecular assays: (1) ribosome footprint profiling experiments, and (2) 
flow cytometry data. 
  
Ribosome footprint profiling describes an in vivo translation profile in a 
living cell and offers insights into the process of post-transcriptional gene 
regulation. Translation efficiency (TE) is a measure that quantifies the rate at 
which active translation is occurring for each gene – defined as the ratio of 
ribosome protected fragment count to mRNA fragment count. We introduce 
pairedSeq, an empirical covariance shrinkage method for differential testing of 
translation efficiency from sequencing data. The method draws on variance 
decomposition techniques in mixed-effect modeling and analysis of variance. 
Benchmark tests comparing to the existing methods reveals that pairedSeq 
effectively detects signals in genes with high variation in expression measurements 
across samples due to high co-variability between ribosome occupancy and 
transcript abundance. In contrast, existing methods tend to mistake genes with 
negative co-variability as signals, as a result of variance underestimation when not 
accounting for negative co-variability. We then present a genome-wide survey of 
primate species divergence at the translational and post-translational layer of gene 
regulation.  
FCM is routinely employed to characterize cellular characteristics such as 
mRNA and protein expression at the single-cell level. While many computational 
methods have been developed that focus on identifying cell populations in 
  
individual FCM samples, very few have addressed how the identified cell 
populations can be matched across samples for comparative analysis. FlowMap-FR 
can be used to quantify the similarity between cell populations under scenarios of 
proportion differences and modest position shifts, and to identify situations in 
which inappropriate splitting or merging of cell populations has occurred during 
gating procedures. It has been implemented as a stand-alone R/Bioconductor 
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Phenotypic variation in multi-cellular organisms arises as a result of 
complex gene regulation mechanisms. Modern development of high-throughput 
technology opens up the possibility of genome-wide interrogation of aspects of 
these mechanisms across molecular phenotypes. A wide array of high-throughout 
biological assays are now available for characterizing DNA structure (e.g., DNA-
seq and transposon sequencing 1,2), DNA-protein interactions (e.g., ChIP-seq 3 and 
DNase-seq 4,5), global transcriptome profile (RNA-seq 6), and more recently, 
genome wide translational level of gene expression control (Ribosome footprint 
profiling 7). Joint collection and analysis of genetic materials can provide valuable 
insights into regulatory patterns that shape phenotype variations 8–12. 
Gene expression profiles are central to understanding protein expression 
patterns that underlie phenotype variation 13–17. When a functional group of genes 
is being expressed in the cell, a chain of reactions is activated to translate encoding 
genetic materials in the DNAs to instructions directing protein synthesis in the 
RNAs, and to modulate protein functions. This chain of gene regulatory actions 
can be summarized in three processes: transcriptional and translational control of 
gene expression and post-translational regulation of protein expression.  
 
 2 
Much of the literature focuses on transcriptional profiling and transcription 
binding factors and on protein expression patterns. We now know transcriptional 
gene expression correlates poorly with protein expression patterns and much work 
is needed to investigate post-transcriptional control of gene expression. For 
example, synonymous mutation is a genetic variant that alters one or more 
nucleotide bases in an encoding gene but does not change the produced amino acid 
sequences. We now know synonymous mutations are instrumental in shaping 
phenotypic variation along with non-synonymous mutations and in modulating 
protein abundance variations via their control of translation initiation and codon 
usage bias.  
Ribosome footprint profiling is a high-throughput biological assay that 
characterizes the in vivo translational profile of a living cell. The joint collection of 
ribosome footprints and transcriptional expression profile can shed light on the 
post-transcriptional control of gene expression. In addition, in conjunction with 
protein expression data, we can begin to investigate in high-resolution the post-
translational modification of amino acid sequences. Multivariate statistical methods 
provide convenient frameworks for modeling and analyzing data obtained from 
high-throughput experiments probing these complex aspects. This dissertation 
presents multivariate statistical methods to analyze data arising from two specific 
 
 3 
high-throughput molecular assays: (1) ribosome footprint profiling experiments, 
and (2) flow cytometry data. 
This thesis begins with a conceptual framework for empirical Bayes methods 
for correlated data. Chapter 2 presents a statistical method developed to identify 
differences in translation efficiency between biological conditions. Chapter 3 
investigates divergence between primate species using data collected at 
transcriptional, translational and protein synthesis layers. Chapter 4 presents a 
statistical method that is developed to compare cell populations homogeneous in 
protein expression profiles.  
 
 4 
2 Empirical Bayes analysis of intra-sample variability improves 
power in differential analysis of translation efficiency 
2.1 Background 
Ribosome footprint profiling experiments allow for the first time a high-
resolution survey of the sites on mRNA molecules undergoing active translation 7. 
Ribosome footprinting has been adopted to survey translational landscapes 18, to 
delineate mechanisms underlying translation initiation and elongation 19,20, and to 
study evolutionary pressure at translational and post-translational regulation 21. 
Initial steps of ribosome footprinting involve capturing and isolating ribosome-
protected mRNA molecules from the mRNA molecules not protected by ribosomes. 
Ribosomal RNAs are then immobilized and depleted from the ribosome-footprint 
complexes. Each ribosome protected fragment is about 28 to 30 nucleotide bases. 
These ribosome protected fragments are size-selected and ligated using the same 
procedure in a typical RNA sequencing experiment. Sequencing reads generated in 
a ribosome footprint profiling experiment are mapped onto the genome using 
alignment tools that are sensitive to spliced mRNA fragments 22.  
Ribosome occupancy data, as measured by the number of ribosome 
protected fragment reads, is count based and can be analyzed with statistical tools 
 
 5 
developed for other sequencing data. Translation efficiency (TE) is a measure that 
quantifies the rate at which active translation is occurring for each gene. It is 
defined as the ratio of ribosome protected fragment count to mRNA fragment 
count. Because the quantity of ribosome protected fragments is dependent on the 
transcriptional expression level of the gene, an overall high variation in expression 
measurements across ribosome footprofiling and RNA-seq data is expected when 
positive co-variation between ribosome occupancy data and transcript abundance is 
present. The unique feature of correlated count data sets the analysis of translation 
efficiency apart from standard RNA-seq analysis. 
Few methods are available for differential analysis of translation efficiency 
23,24. Olshen et al. (2013) propose a count based statistical framework that proceeds 
in two steps. First, per gene per sample measurements are analyzed to quantify the 
degree to which ribosome occupancy level differs from what would be expected 
given its transcript abundance. An errors-in-variables regression model is performed 
on ribosome occupancy measurements using corresponding sample transcript 
abundance as a covariate. The P-value associated with the transcript abundance 
covariate is used to quantify the magnitude of translational regulation. Next, P-
values within each biological condition are transformed to Z-scores. These Z-scores 
are then compared between conditions to determine significance of condition 
 
 6 
differences in translational regulation. Zhong et al. 24 applies the DESeq2 
framework and compares translation efficiency using an interaction design. The 
design matrix has four Boolean-valued columns: a column indicating data type 
(ribosome footprinting or RNA-seq), a column corresponding to biological condition 
(1 or 2), a column for interaction (data type by condition), and finally, a column of 
1's describing the model intercept. This model assumes the independence of 
ribosome protected fragment count and transcript abundance. 
We describe a conceptual framework for the analysis of translation 
efficiency, using an established approach in the analysis of DNA microarray where 
probe intensities are modeled on a log scale. This approach can be easily 
incorporated into complex experimental designs such as split-plot and time series 
experiments. Recently, Law et al. (2014) presented voom, a statistical framework 
for RNA-seq data in which the standard deviation of log2 counts per million 
(CPM) is proved to be mathematically equivalent to the dispersion parameter in a 
negative binomial distribution, given large library size 25. The voom algorithm 
computes an observational-level precision weight to adjust for heterogeneity of 
variances commonly observed in RNA-seq data.  
Small sample size in sequencing experiments is a core challenge in statistical 
analysis of RNA-seq data. Empirical Bayes shrinkage is routinely applied to 
 
 7 
stabilize variance estimates across genes. In differential analysis of translation 
efficiency, we are also concerned with co-variability between sample measurements 
obtained from ribosome profiling experiments and RNA-seq experiments. We 
introduce pairedSeq, an empirical covariance shrinkage method for differential 
testing of translation efficiency from sequencing data. 
 
2.2 Methods 
In a typical experiment designed to compare translation efficiency between 
biological conditions, both ribosome occupancy and mRNA transcript abundance 
are collected for 𝑛 cell lines. A total of 2𝑛 samples are prepared for each 
experiment. Per gene log2-cpm values (𝐘!,! ,𝐙!,!)! are computed for ribosome 
occupancy and transcript abundance, respectively, in cell line 𝑖. The 𝑛 pairs of 
samples are assumed to be independent and identically distributed and follow a 
multivariate normal distribution with mean 𝛍! and covariance matrix 𝚺!, denoted 
by 𝑁!(𝛍!,𝚺!). 
The main interest in this paper is to describe and model 𝚺!. Later on, we 
describe various covariance structures that are evaluated in this paper. For now, 
the covariance matrix of (𝐘!,! ,𝐙!,!)! is described as unstructured: 
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where  τ!,!!  and τ!,!!  denote the variability within each data type across samples in 
log2-cpm values of ribosome occupancy and transcript abundance, respectively, and 
τ!,!!  represents intra-sample variability in gene 𝑔 across 𝑛 cell lines – covariation 
between ribosome occupancy and transcript abundance for each gene. The 
quantities 𝐘! and 𝐙! denote gene 𝑔's vector of log2-cpm values of ribosome 
occupancy and transcript abundances, respectively, and are match-ordered 










2.2.1 Variance-mean dependency 
We adopt voom, a log2-cpm based approach for variance-mean dependency 
across ribosome occupancy data and RNA-seq data 25. A nonparametric function of 
per gene log2-cpm values of expression is fitted across ribosome occupancy and 
transcript abundance measurements across genes to describe the per gene observed 
squared standard deviation of the log2-cpm measurements. The fitted 
nonparametric trend measures the degree of variance-mean dependency across data 
types. The nonparametric fit computes predicted variances of expression values at 
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the observational level, which represents the magnitude of variance-mean 
dependency in the data. The inverse of the predicted variances are used as 
observation weights to remove the variance-mean dependency for all subsequent 
analyses. The voom precision weights are proven to downweight inflated variances 
among weakly expressed genes in data sets of small to large numbers of biological 
replicates. See Law et al. 25 for a comparison of voom with the count-based 
methods. 
Denote 𝐖! = diag(w!,!,… ,w!,!) as gene 𝑔's voom precision weights, for a 
total of 𝑁 = 2𝑛 samples of expression values. The unstructured covariance matrix 





where we assume homogeneity of variances across data types. 
2.2.2 Model 
The log2-cpm values of ribosome occupancy and transcript abundance are 










where 𝐗𝛃! models the fold change in translation efficiency between biological 
conditions, 𝔼 𝐘!! ,𝐙!! ! = 𝐗𝛃!, and 𝐗 represents a 2𝑛  ×  4 interaction design matrix 
that indicates sample membership in each data type and each biological condition 
under study. For example, suppose there are two biological conditions in the 
comparison The columns of 𝐗 includes a main effect column of condition (1 = 
Condition 1, 0 = Condition 2), a main effect column of data type (1 = ribosome 
occupancy, 0 = RNA-seq), and an interaction effect column (condition column 
multiplied by the data type column componentwise), with a column of 1's for the 
intercept. 𝛈!,!!  and  𝛈!,!!  represent the residuals in ribosome occupancy and 
transcript abundance after weighting the data for variance-mean dependency, and 
                      Cov η!,! , η!,! = Δ! =
σ!! σ!,!!
σ!,!! σ!!
⊗ 𝐈!.                            
Error! Reference source not found.                   
The coefficient vector 𝛃! consists of four effects corresponding to the columns in 
the interaction design matrix. Each of the coefficients is estimated by a linear 
combination of four average sample expression values of samples: Ribosome 
occupancy in condition 1 and 2, and RNA-seq in condition 1 and 2. Let 𝐘!,! and 
𝐙!,!  denote gene g’s average log2-cpm values of ribosome occupancy and transcript 
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abundance in condition l. We let β!!"as the fold change in translation efficiency and 
compute  
𝛽!!" =   𝐘!,! −   𝐙!,! − (𝐘!,! − 𝐙!,!), 
between condition k and l. Following the linearity of 𝛽!!", the variance of the fold 
change estimate is computed a weighted sum of the two sources of within-data-
type variability and intra-sample variability,    







where n! and n! are the number of cell lines collected for condition k and l, 
respectively.  
2.2.3 Empirical Bayes shrinkage for intra-sample variability  
We draw on variance decomposition techniques in the statistical literature 
of mixed effect modeling and analysis of variance and suggest an empirical 
shrinkage method that can work with both negatively and positively valued intra-
sample co-variability. Briefly, the intra-sample variability or co-variability between 
log2-cpm values of ribosome occupancy and transcript abundance is transformed to 
a linear combination of independent random variables following chi-squared 
distributions. The conjugacy of the chi-square distribution with the inverse-gamma 
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distribution offers closed form solutions for the prior and posterior estimates. The 
posterior estimates of the independent chi-squared random variables are inverse-
transformed to obtain a shrunken estimate of intra-sample variability. This section 
is divided into two parts. First, we describe variance decomposition techniques 
borrowed from mixed-effect modeling and restate our covariance matrix 
accordingly. Then, the linear transformation for obtaining independent variance 
components is delineated, followed by the covariance shrinkage method.  
Variance decomposition using mixed effect modeling 
Under the nested design of ribosome occupancy experiment, each gene’s 
variability in expression levels across samples are of varying magnitude from 
variability across cell lines or random perturbation in expression measurements. 
We explicitly model cell line variability as a random effect and restate the normal 
linear model in Error! Reference source not found. as a mixed-effect model, 
𝐘!
𝐙!
= 𝐗𝛃! + 𝐔𝛄! + 𝛜!,                                Error! Reference source not 
ound. 
where 𝐔 is an 𝑁  ×  𝑛 design matrix consisting of Boolean-valued vectors that 
indicates each sample’s cell line membership, γ! is a length-𝑛 coefficient vector 
that correspond to the random effect design matrix 𝐔, and 𝛜! contains residuals 
estimating random perturbation in expression measurements across samples that is 
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independent of cell line variability. We assume that 𝛄! and 𝛜! are independent and 
distributed as 𝑁(0,σ!,!! 𝐈!) and 𝑁(0,σ!,!! 𝐈!), respectively. Thus, the covariance 
matrix of 𝛜!,    
𝐶𝑜𝑣[𝛜!, 𝛜!  ] = σ!,!! 𝐔𝐔! + σ!,!! 𝐈!, 
is equal to the weighted covariance matrix in Error! Reference source not 





σ!,!! + σ!,!! σ!,!!
σ!,!! σ!,!! + σ!,!!




σ!,!! + ,!! σ!,!!
,!
! σ!,!! + σ!,!!
⊗ 𝐈!, 
states that the explicit modeling of variability across cell lines leads to the 
decomposition of within-data-type variability σ!! into variability generated from (1) 
σ!,!!  the variability across cell lines between log2-cpm values of ribosome occupancy 
and transcript abundance, or equivalently, the intra-sample variability or co-
variability between the two data types, and (2) σ!,!!  the variability across sample 
measurements that estimates random perturbation in expression measurements, or 
equivalently, within-data-type expression variability.  
 Our main objective in applying mixed-effect modeling is to obtain a 
representation of covariance matrix that delineates variation from intra-sample 
variability and random perturbation in expression measurements. Therefore, we 
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require the covariance matrix 𝚫! = σ!,!! 𝐔𝐔! + σ!,!! 𝐈! to be positive semidefinite, 
rather than putting constraints on the individual variance components.  
Empirical Bayes shrinkage in Analysis of variance components 
Analysis of variance (ANOVA) is a statistical tool for complex data structures such 
as nested designs that decomposes observation into orthogonal components and 
offers empirical estimates of variance components with easy-to-work-with 
distributional properties. Under the assumption of normality and balance of the 
data structure, they are independent and follow scaled chi-squared distributions 26. 
The conjugate prior of scaled chi-squared distribution is inverse-gamma, which 
offers closed form solution of posterior estimate. Most importantly, ANOVA 
estimation permits negatively valued shrunken intra-sample covariance estimates. 
Typical Bayesian analysis of variance components σ!,!!  and σ!,!!  assumes conjugate 
prior of inverse-gamma, which constrains the posterior parameter space to be 
strictly non-negative 27. Our approach puts the parameter space σ!,!!  on a real line. 
This section describes a linear transformation of variance components to ANOVA 
components and the covariance shrinkage method 28,29.  
From the analysis of variance perspective, the mixed-effect model in Error! 
eference source not found. gives rise to two sources of variation that have a 
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one-to-one relationship with the variance components σ!,!!  and σ!,!! . The total 
intra-sample sum-of-squares (SSB) computes the sum of squared deviations of 
expression measurements in each cell line; this is a function of co-variability of 
expression values between data types and also random perturbation of 
measurements within each data type. The within-sample sum-of-squares (SSW) 
computes the sum of squared deviation of each sample’s expression value from the 
mean gene expression level. ANOVA components are the averaged sum-of-squares 
divided by corresponding degrees of freedom. Let AC!,! denote the per gene 
ANOVA component corresponding to SSB. Then AC!,! = SSB/𝑑𝑓!!", where degrees 
of freedom of intra-sample sum-of-squares is the number of cell lines minus 1 
(𝑛 − 1). Let AC!,! denote the per gene ANOVA component corresponding to SSW. 
Then AC!,! = SSW/𝑑𝑓!!", where degrees of freedom of within-sample sum-of-
squares is the total number of samples minus the number of cell lines (𝑁 − 𝑛). 
Each of the ANOVA components follows a chi-squared distribution 
AC!,! ∼
2σ!,!! + σ!,!!









𝔼AC!,! = 2σ!,!! + σ!,!!           and          𝔼AC!,! = σ!,!! .    
Given the above relationship, we can estimate the per gene ANOVA 
components as 
AC!,! = 2σ!,!! + σ!,!!           and          AC!,! = σ!,!! ,                                                                    Error!  Reference  
ource  not  found.  
where σ!,!!  and σ!! denote the estimated variance components based on observed 
data, and   AC!,!  and  AC!,!    denote the corresponding sample estimates of ANOVA 
components. Conversely, suppose we only have information on the ANOVA 
components. Then, we can compute 
σ!,!! = (AC!,! −   AC!,!)/2            and            σ!,!! = AC!,! .                                                              Error!  Reference  
ource  not  found.  
Shrunken estimates of σ!,!!  and σ!,!!  are computed in three steps. First, we 
estimate gene-wise component estimates using restricted maximum likelihood 
estimation method (REML). The variance component REML estimates are then 
transformed to ANOVA components 28. Second, we estimate prior parameters of 
the likelihood ANOVA components following the chi-squared-and-inverse-gamma 
family conjugacy. Finally, we combine the likelihood and the prior density to 
obtain posterior estimates of the ANOVA components. The posterior ANOVA 
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estimates are then inverse-transformed to obtain our posterior estimates of variance 
components.  
Gene-wise ANOVA component estimates. We start with the model in Error! 
eference source not found. and compute the per gene REML estimates of 
variance components, denoted as σ!,!!  and σ!,!! . The weighted variance-covariance 
matrix 𝚫! is required to be positive semi-definite. σ!,!!  and σ!,!!  are the converted 
to the per gene ANOVA estimates AC!,!  and  AC!,! using Error! Reference 
ource not found.. 
ANOVA prior estimates. Recall that each ANOVA component follows a chi-
squared distribution, and denote the parameter of AC!,! as σ!,!"_!! = 2σ!,!! + σ!,!!  
and the parameter of AC!,! as σ!,!"_!! = σ!,!! . Then, σ!,!"_!!  and σ!,!"_!!  each follows 















where AC!,! and AC!,! are prior parameter for the gene-wise ANOVA components, 
and d!,! and d!,! are their corresponding degrees of freedom.  
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Prior parameters are estimated using a computational efficiency approach 
that is implemented in Smyth’s limma algorithm 30. Briefly, take AC!,! as an 
example. The ANOVA components are log2 transformed, and the two equations 
are set up equating log2-ANOVA sample moments with population moments  
𝔼 [log  AC!,!] = log  AC!,! + ψ(d!,!/2)− ψ(d!,!/2)+ log(d!,!/d!,!) 
𝕍𝕒𝕣[log      AC!,!] = ψ!(d!,!/2)+ ψ!(d!,!/2) 
where ψ(. ) and ψ!(. ) are the digamma and trigamma function, respectively. The 
hyperparameters are computed in two steps. First, using delta method, we 
approximate the value of d!,!. Given the estimate for d!,!, we obtain the estimate 
for AC!,!. Details of the computational steps for each estimator can be found in 
Smyth’s limma paper. 30  
ANOVA shrunken estimates. Posterior densities of the ANOVA components 
distribute as scaled-inverse-chi-squared distributions, provided that AC!,! spans the 
positive real line 31. The shrunken estimates are the values at which the posterior 
density is maximized. Thus, posterior estimates are also referred to as maximum a 
posteriori estimates. The shrunken estimates AC!,! and AC!,! for the intra-sample 








AC!,! ∗ d!,! + AC!,! ∗ d!,!
d!,! + d!,!
 
with d!,! + d!,! and d!,! + d!,!degrees of freedom, respectively. 
The final shrunken variance estimates are obtained by inverse-transforming AC!,! 
and AC!,!: 
σ!,!! = (AC!,! − AC!,!)/2      and      σ!,!! = AC!,!. 
Hypothesis testing 
A moderated t-statistic is used to test the null hypothesis whether there is a 




σ! 𝐜!𝐗! σ!,!! 𝐔𝐔! + σ!,!! 𝐈!
!!𝐗𝐜
 
where 𝐜 = c(0,0,0,1)!, σ! = σ!,!! + σ!,!! , 𝛽!!" is the estimated log2 fold change of 
translation efficiency between the two conditions 32, and 𝐗 is the interaction design 
matrix. For degrees of freedom, we need to consider the posterior density of σ!,!!  
and σ!,!! . The posterior density of σ!,!!  is known and equivalent to the posterior 
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density of AC!,!, which is distributed as an inverse-scaled-chi-squared distribution 
with d!,! + d!,! degrees of freedom. σ!,!!  is effectively a linear combination of two 
inverse-scaled-chi-squared random variables. The density of σ!,!!  is mathematically 
intractable and difficult to compute 33. Therefore, we arbitrarily chose two values of 
degrees of freedom for σ! and compared the performance of our method under each 
setting: 1) sum of the degrees of freedom of the two posterior ANOVA components 
(d!,! + d!,! + d!,! + d!,!), 2) the degrees of freedom of the within-sample ANOVA 
component (d!,! + d!,!). These two settings represent our belief in the reliability of 
sample information. The first setting is lenient and assumes all sample information 
is usable; the second setting is conservative and assumes a small effective sample 
size based on the number of cell lines.  
2.2.4 Comparative benchmarks 
Benchmark tests follow the procedures described in Love et al. 34. The performance 
of pairedSeq is evaluated and compared with LMM (linear mixed model), voom 25, 
and DESeq2 34. LMM and voom are normal-based models that perform differential 
testing on log2-cpm values of read counts in ribosome occupancy data and in 
transcript abundance. LMM assumes a gene-wise intra-sample variability and 
reports results without empirical shrinkage of variance components, while voom 
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models a gene-wide intra-sample variability measure and performs empirical 
shrinkage on within-sample variability in expression measures. DESeq2 is a count-
based model that performs shrinkage on both fold change and within-sample 
variability, but the method does not support intra-sample variability specification.  
Data sets 
Three real data sets from ribosome profiling experiments are discussed and 
presented for features of ribosome occupancy data. In addition, we use these data 
sets to construct simulated data sets for comparative benchmark tests. 
Yoruba40: This data set includes lymphoblastoid cell lines (LCLs) derived from 40 
unrelated female Yoruba individuals. The RNA-seq data was collected in Pickrell 
et al. 15, and ribosome occupancy data was collected in Battle et al. 35. 
Primate5: This data set includes LCLs derived from 6 Yoruba individuals and 5 
rhesus monkey individuals. The RNA-seq part of the data was collected in Khan et 
al. 36, and ribosome occupancy data was collected in Wang et al. 37. 
Yeast4: McManus et al. 21 performed both RNA-seq and ribosome footprint 
profiling on two strains of yeast (S. cerevisiae and S. paradoxus). Four samples 
were collected for each strain of yeast.   
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Sensitivity and precision  
The power performance of each differential test is evaluated using Primate5, 
following the design delineated in Love et al. 38. The basic idea is to assess the 
sensitivity and precision of each differential test where the true calls of genes with 
differential translation efficiency are constructed from the comparison tests. The 
data set in which the true calls are made is referred to as the target set, and the 
data set in which the true calls are assessed is called the evaluation set. The 
samples of ribosome occupancy and transcript abundance are matched on the cell 
lines from which they are derived. The cell lines are the randomly assigned to the 
target set and the evaluation set, with 3 human versus 2 rhesus samples in the 
target set and 2 human versus 2 rhesus samples in the evaluation set. Each 
simulation constitutes a random assignment of target set and evaluation set. The 
number of possible random assignments is determined using the number of cell 
lines in each condition. Primate5 consists of 6 human versus 5 rhesus samples; thus 
there can be a maximum of 10 pairs of target set versus evaluation set. For each 
pair of target versus evaluation set, we apply each of the 5 differential tests to 
establish true calls at a series of false discovery rate less than .05 to .5 with .5 
increments. The same procedure is applied to the evaluation set to identify the 
significant genes.  
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Sensitivity is defined as the proportion of true positives (among the genes 
that passed the FDR threshold as true call in the target set, the proportion of 
those that are identified as significant in the evaluation set). Precision is defined as 
the proportion of true positives among genes identified as significant in the 
evaluation set (among the genes passed the FDR threshold in the evaluation set, 
the proportion of those that are identified as a true call in the target set). At each 
nominal adjusted p-value threshold, we computed the mean and standard error of 
power and precision for each differential test of translation efficiency.  
False discovery rate 
Simulated data sets are constructed from Yoruba40, a data set in which the 
samples do not represent known biological conditions. False discovery rate is 
computed for two experimental settings with 10 and 30 cell lines across 50 
simulated data sets. In each simulated data set, we matched samples of ribosome 
occupancy and transcript abundance that are derived from the same cell line. We 
then randomly selected cell lines from the 40 cell lines in the original data without 
replacement. Next, two sets of arbitrary condition labels are assigned to the 
selected cell lines. These cell lines are not expected to differ in translation efficiency 
between the two arbitrary assigned conditions. We then performed differential 
testing of translation efficiency using pairedSeq and the comparison methods. 
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Significant call of fold change in translation efficiency was set at false discovery 
rate less than .005, .01, .05, and .1. For each differential test of translation 
efficiency, we compute the proportion of significant genes out of the total number 
of genes in each simulated data set and averaged across the 50 simulation 
experiments.  
2.3 Results and discussion 
2.3.1 Variance and mean dependency 
 The trend of variance dependency on mean in log2-cpm values of read 
counts is evaluated in all three real data sets. Figure 2 shows for each real data set, 
the fitted nonparametric relationship between variance and mean using locally 
weighted scatter plot smoothing (loess). The trend fit is similar between ribosome 
occupancy data and in RNA-seq data, especially among the highly expressed genes. 
Among the lowly expressed genes, there is a stronger dependency of the variances 
on the mean of the log2-cpm values in the ribosome occupancy data in Yoruba40 
and Primate5. However, in the yeast data Yeast4, the variance-mean dependency is 
similar across all levels of mean log2-cpm values of read counts. In all subsequent 
analyses shown here, we modeled the variance-mean trend across the two data. 
The voom precision weights were computed using the cross-data-type variance-
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mean trend fit and used to weight covariance matrices of each gene in differential 
testing of translation efficiency.  
2.3.2 Co-variability between ribosome occupancy and transcript abundance 
 We characterized co-variability between ribosome occupancy and transcript 
abundance in data sets before correcting for variance-mean dependency. Figure 3 
presents per gene correlations between ribosome occupancy levels and transcript 
abundances in Yoruba40. Across the genes, there is a positive relationship between 
log2-cpm values of ribosome occupancy and transcript abundance for a single 
sample and also for averaged expression values across samples (Figure 3a,b). This 
phenomenon is frequently cited as one of the supports for the quality of ribosome 
footprinting experiments. However, we observed that this positive relationship does 
not hold at the gene level. The correlations between ribosome occupancy and 
transcript abundance vary from -1 to 1, with the median suggesting a positive 
correlation (Figure 3c). This variation in gene-level co-variability is consistent 
across levels of translation efficiency and also gene expression level as in log2-cpm 
values (Figure 3d,e).  
Next, we ask whether the co-variability may differ as a function of biological 
conditions in Primate5 and Yeast 4. Primate5 consisted of human and rhesus 
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monkey samples and are expected to exhibit high biological variability in 
expression measurements. Yeast4 is a data set of low biological variability which 
includes two closely related yeast strains. Figure 4a and Figure 4c display cross-
species co-variability between ribosome occupancy and transcript abundance. The 
correlations spans -1 to 1 in both data sets, with distribution skewed to the left, 
indicating a large number of genes with positive co-variability between ribosome 
occupancy and transcript abundance. This result is not surprising, given that 
samples with high biological variability present a wide dynamic range of possible 
data values, and hence are likely to present high co-variability between samples.  
In Figure 5, genes are ranked by co-variability between ribosome occupancy 
and transcript abundance and plotted for their log2-cpm values of variance versus 
mean gene expression values. We observed a tendency for genes with high co-
variability to exhibit high variance in the data and vice versa for genes with low 
co-variability. This trend is consistent across differing levels of gene expression and 
hence persists after correlation for variance-mean dependency in the data. Figure 
4b and d further compare per gene correlations between species and shows that co-
variability is not a function of species difference in Primate5 or Yeast4.  
Figure 6a,b demonstrate that among genes with large co-variability, there tends to 
be a larger fold change or species difference in translation efficiency. This 
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dependency cannot be accounted for by the voom variance-mean dependency 
correction, and persists after adjusting for different levels of variances in log2-cpm 
values (Figure 6c,d).  
The intra-sample co-variability between ribosome occupancy and transcript 
abundance can be negatively valued in a ribosome occupancy experiment because it 
corresponds to covariation between log2-cpm values of ribosome occupancy and 
transcript abundance. We note that a negative variance component violates the 
assumption of mixed-effect modeling under the hierarchical framework where intra-
sample co-variability represents the variance parameter of a normal random 
variable. Suppose we are interested in making inferences about sample 
measurements at the cell line level, a negatively valued variance component would 
suggest that cell line variability follows a normal distribution with negative 
variance parameter. Since we are not interested in making inferences at the cell line 
level, a negative variance component is not so much of a concern.  
2.3.3 Shrunken covariance estimates and differential translation efficiency 
Figure 7 compares correlation estimates observed in Primate5 with the 
shrunken correlation estimates. pairedSeq shrinks correlation in both genes with 
positive and negative correlation between log2-cpm values of ribosome occupancy 
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and transcript abundance. The shrinkage is stronger among genes with positive co-
variability. Figure 8 compares significance finding of pairedSeq with voom and 
DESeq2 in Primate5 at false discovery rate of .01. When compared to voom, we 
observed that pairedSeq is able to pick up genes with high fold change in 
translation efficiency, especially for genes with high and positive co-variability 
between ribosome occupancy and transcript abundance. On the other hand, voom 
tends to pick up genes with lower fold change in translation efficiency and with 
negative co-variability. In voom, a single positive correlation is used to model co-
variability in the observed expression values without any empirical shrinkage. 
While, pairedSeq allows the observed co-variability to vary across genes and also 
performs empirical shrinkage on covariance estimates. Because co-variability is 
associated with high variability in the expression values, by shrinking co-variability 
in significance testing, pairdSeq is able to uncover signals that would be otherwise 
difficult to detect. Similar findings were observed when comparing pairedSeq to 
DESeq2, which provide shrinkage on fold change and variance estimates but not on 
covariance estimates. pairedSeq picks up signals with higher fold change than 
DESeq and these signals are genes with positive co-variability.  
Negative co-variability between ribosome occupancy and transcript 
abundance indicate that the samples have a differing order of magnitude in 
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ribosome occupancy than in transcript abundance data. We believe that such a 
difference, if it were observed between species, would be the result of biological 
variance between samples. However, we observed many of the genes with negative 
co-variability to have differing order of magnitude between data types within 
species. Such phenomenon may be due to experimental artifacts in the ribosome 
footprinting experiment. A sensible differential test of translation efficiency should 
avoid calling genes in which expression values are confounded by experimental 
artifacts. Compared to both voom and DESeq2, pairedSeq is able to pick up genes 
with strong biological variation in the data instead of genes with experimental 
artifacts.  
We performed a series of benchmark tests based on simulated data 
generated from Primate5 and compared pairedSeq’s sensitivity, precision, and false 
discovery rate with voom, LMM, and DESeq2. Figure 9 and Figure 10 illustrate the 
power and sensitivity of pairedSeq using a nominal adjusted p-value threshold of 
.01. pairedSeq has higher sensitivity than DESeq2, voom, and LMM. pairedSeq-r is 
a version of pairedSeq with the moderated t-statistic computed at a conservative 
degrees of freedom. pairedSeq-r is also comparable in sensitivity with DESeq2. 
Precision of voom is the highest among all methods, followed by DESeq2, 
pairedSeq and LMM. In summary, the benchmark tests illustrate that pairedSeq is 
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effective in controlling false discovery rate and in detecting true positives of 
differential translation efficiency.  
 
2.4 Conclusion  
 We introduce pairedSeq, a statistical method designed for the integrated 
analysis of ribosome footprint profiling and RNA-seq to identify phenotype 
differences in translation efficiency. The method explicitly models co-variability in 
ribosome occupancy and transcript abundance, a source of variation that directly 
affects the dynamic range of expression measurements in the analysis of translation 
efficiency. Positive co-variability indicates that a strong biological variation in the 
data, while negative co-variability suggests potential technical artifacts in the 
experiment. Empirical Bayes shrinkage is proposed for co-variation between 
ribosome occupancy and transcript abundance. Results indicate that pairedSeq 
effectively shrinks covariance estimates and is able to identify differences in 
translation efficiency in samples with high measurement variability. Future work 
can extend the proposed covariance shrinkage method to the joint analysis of 











Figure 1. Gene count distributions vary between ribosome occupancy data and 
RNA-seq data. 
Three real data sets are presented here. (a) Lympholastoid cell lines (LCL) derived 
from 40 unrelated female Yoruba individuals. (b) LCLs derived from 6 human 
Yoruba individuals and 5 rhesus money individuals. (c) Four S. cerevisiae and 4 S. 





Figure 2. Variance-mean dependency in 3 real data sets. 
(a) LCL from 40 female individuals. (b) 6 human individuals and 5 rhesus monkey 










Figure 3. Correlation between ribosome occupancy and transcript abundance. 
Data set includes 40 unrelated Yoruba female individuals. (a) Plotted is each 
gene’s log2-cpm values of ribosome occupancy versus transcript abundance in 
NA18499. (b) Plotted is each gene’s average value across samples in log2-cpm of 
ribosome occupancy and transcript abundance. (c) Frequency distribution per gene 
rank correlation between log2-cpm ribosome occupancy and transcript abundance. 
(d) log2 translation efficiency (TE) was computed for each gene as difference 
between sample averages of log2-cpm value of ribosome occupancy and transcript 
abundance. Each purple line represents a gene: the length indicates the size of the 
log2 TE and the x-coordinate of the line indicates the magnitude and directionality 
of the gene’s rank correlation between log2-cpm values of ribosome occupancy and 
transcript abundance. (e) Plotted is each gene’s mean log2-cpm values across 







Figure 4. Per gene correlation between ribosome occupancy and transcript 
abundance across species. 
Plots (a) and (b) are based on a data set of 6 human individuals and 5 rhesus 
monkey individuals. (a) Frequency of per gene rank correlation between log2-cpm 
values of ribosome occupancy and transcript abundance across samples (b) Plotted 
is each gene’s correlation between ribosome occupancy and transcript abundance in 
human individuals versus its correlation in rhesus money individuals. (c) and (d) 
are based on a data set of 2 yeast strains (4 samples each). (c) Frequency of per 
gene rank correlation between log2-cpm values of ribosome occupancy and 
transcript abundance across samples (d) Plotted is each gene’s correlation between 
ribosome occupancy and transcript abundance in S. paradoxus  versus correlation 




Figure 5. Variance and mean trend among genes with high and with low 
correlation between ribosome occupancy and transcript abundance. 
Based on a data set of 6 human individauls and 5 rhesus money individuals. We 
computed Spearman’s rank correlation between log2-cpm values of ribosome 
occupancy and transript abundance. Two sets of genes are of particular interest: 
the top 100 genes and the bottom 100 genes in correlation. Plotted is per gene 
log2-cpm values variance across sampes and the average log-cpm values across 
samples. Blue dots indicate genes with top 100 correlations. Red dots indicate 






Figure 6. Species difference in translation efficiency is larger for genes with positive 
correlation between ribosome occupancy and transcript abundance. 
Plotted is per gene log2 fold change in translation efficiency versus per gene’s rank 
correlation between log2-cpm ribosome occupancy and transcript abundance across 
all samples. (a) based on a data set of 6 human individuals and 5 rhesus monkey 







Figure 7. pairedSeq shrinks both positive and negative correlations between 
ribosome occupancy and transcript abundance. 
Plotted is each gene’s shrunken correlation coefficient based on the pairedSeq 
method and the observed sample rank correlaion coefficient. Blue dots represent 
genes with positive observed correlation. Purple dots depict genes with negative 





Figure 8. pairedSeq detects significant fold change despite high intra-sample 
variability.  
Results are based on a real data set of 6 human individuals and 5 rhesus monkey 
individuals. We performed tests of differential translation efficiency at false 
discovery rate < .01. (a) Compares significant calls in voom and in pairedSeq. Red 
line represents genes identified as significant in pairedSeq but non-significant in 
voom. Blue lines depicts genes identified as significant in voom but non-significant 
in pairedSeq. (b) Compares significant calls in DESeq2 and in pairedSeq. Red line 
represents genes identified as significant in pairedSeq but non-significant in 
DESeq2. Blue lines depicts genes identified as significant in DESeq2 but non-






Figure 9. Benchmark sensitivity in pairedSeq, pairedSeq-r, DESeq2, voom, and 




Figure 10. Benchmark precision in pairedSeq, pairedSeq-r, DESeq2, voom, and 






Figure 11. Benchmark false discovery rate in pairedSeq, pairedSeq-r, DESeq2, 
voom, and LMM.  
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3 Comparative genomic study between primates 
3.1 Abstract 
Mechanistic descriptions of gene regulation differences between homo 
sapiens and its closely related species, the chimpanzee, is likely to reveal principles 
determining phenotypes that are distinctly human. Although gene expression is a 
multi-step process, the bulk of the literature concerning gene expression in 
primates is focused on transcript level and transcription factor binding differences. 
This transcription centered view of gene regulation disregards more than half of the 
process and is therefore potentially misleading. To gain a comprehensive view on 
gene regulation, we surveyed genome wide ribosome occupancy levels in five 
lymphoblastoid cell lines (LCL) each derived from humans, chimpanzees and 
Rhesus macaques to estimate translation level divergence in primates. We 
performed integrative analysis on gene regulation, combining mRNA level and 
protein level measurements we previously collected from matching cell lines. We 
found that translational level divergence often propagates existing divergence at 
the transcript level between humans and chimpanzees. For genes that show 
differences in divergence between RNA and protein levels, we estimate about 30% 
are mediated through translational regulation. The majority of the differences in 
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protein-RNA divergence, however, are explained by post-translational attenuation, 
likely mediated through post-translational modifications. This attenuation is 
conserved across the three primate species studied here. It appears that the 
divergence attenuation could evolve under stabilizing selection of protein 
expression levels to serve as a buffering mechanism maintaining homeostasis 
against perturbations from environment or genetic variations. Finally, we observed 
increased variations in mRNA levels for buffered genes in a human population, 
indicating relaxation of selective constrain on transcript levels for buffered genes in 
recent human evolution. 
 
3.2 Background  
Differences in gene regulation are the major factors determining phenotypic 
variations between closely related species 39,40. Alterations of tissue specific gene 
expression patterns of essential genes is more likely to survive natural selection 
than coding substitutions, which would result in ubiquitous effects that often sum 
up to a negative net impact on the fitness level of an organism 41. Almost half a 
century ago, based on examination of coding substitutions between human and 
chimpanzee, King and Wilson 42 postulated that gene regulation differences are 
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more likely to be the major factor driving the phenotypic divergence. Over the past 
decade, ample studies surveying gene expression variation in primates reached 
conclusions concurring with this hypothesis 17,43–45. Consistently, population 
genomics studies looking for signatures of recent selection also highlighted the key 
roles of regulatory variations in human adaptation 46,47. 
Even though it is clear that protein expression levels are the relevant 
quantities for coding genes, most studies investigating variations in gene expression 
among primates focused on comparing expression levels of mRNA 17,43,48,49. While 
the general efficacy of using mRNA level as a proxy for estimating protein levels is 
still up for debate 50, it is clear that in some instances translational and/ or 
posttranslational regulation of gene expression resulted in protein levels that far 
diverged from the mRNA levels upstream 51. In fact, it has been shown that protein 
expression levels are far more conserved across diverse taxa than mRNA levels 52. 
How this conservation of protein levels is achieved given the apparent divergence 
at the mRNA level is still unclear.   
To estimate the divergence between mRNA and protein levels in primates, 
we previously collected RNA-sequencing and quantitative mass spectrometry data 
from a set of 15 primates (5 humans, 5 chimpanzees and 5 Rhesus monkeys) 
Lymphoblastoid Cell Lines (LCL). Consistent with the earlier observation across 
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wider taxa, we found extensive variations in mRNA levels between human and 
chimpanzee, which were attenuated by some downstream processes and resulted in 
a conserved protein expression level 53. While a stronger evolutionary constraint at 
the protein expression level is in line with the fact that proteins form the 
machineries that execute biological functions, it remains unclear whether the 
attenuation occurred translationally or post translationally.  
Ribosome profiling is a technique utilizing next generation sequencing to 
survey ribosome footprints in a massively parallel fashion 7. It has been shown that 
ribosome occupancy levels estimated from counting number of ribosome footprint 
sequencing reads are good approximations for the level of protein translation 54. We 
have recently applied this technique in a panel of HapMap cell lines to identify 
genetic variants regulating translation and to estimate relative contribution of 
translational and posttranslational regulation to steady state protein levels 55. We 
found that even within the human population, protein level tend to be less variable 
than mRNA level. Interestingly, variations of translation levels tend to be in 
concordance with mRNA rather than protein, indicating a major role of post-
translational processes in variation attenuation.  
To further investigate this property across primates, we performed ribosome 
profiling experiments on the same five chimpanzee and five rhesus cell lines as 
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reported in Khan et al. 53. Through integrative analysis of ribosome profiling data 
and quantitative mass spectrometry data, we estimated the contribution of 
translational regulation in attenuating gene expression variations to achieve a 
conserved protein levels across primates. Our results suggest that a post-
translational gene expression buffering mechanism evolved under stabilizing 
selection of protein expression levels. To our knowledge, our dataset provides the 
first global view on translational landscape across primates. This dataset also 
allowed us to interrogate the regulatory relationships across different layers of gene 
expression phenotypes and their roles in primate evolution.   
 
3.3 Methods  
3.3.1 Ribosome footprint profiling 
We collected ribosome occupancy data from Epstein-Barr virus (EBV)-
transformed lymphoblastoid cell lines (LCLs) derived from five human (Coriell 
YRI, NIGMS Human Genetics Cell Repository, GM18585, GM18507, GM18516, 
GM19193, GM19204) and five chimpanzee (Pan troglodytes) individuals (New 
Iberia Research Center: Min 18358, Min 18359; Coriell/IPBIR: NS03659, NS04973, 
Arizona State University, Pt91). Data also collected from rhesus Herpesvirus papio 
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transformed LCLs from five rhesus macaque (Macaca mulatta) individuals 
(Harvard Medical School, NEPRC: 150-99, R181-96, R249-97, 265-95, R290-96). 
Cell culture work followed the same procedure as previously described 55. Ribosome 
profiling experiments were performed using the ARTseqTM Ribosome Profiling kit 
for mammalian cells (RPHMR12126) following vendor’s instructions, with minor 
modifications that we described in Battle et al. 55. Flash frozen pellets of 30 to 50 
million cells were used for each experiment. Preprocessing of sequencing data 
followed the procedure used by Ingolia et al. 56. Mapping of processed reads and 
counting for estimating orthologous gene expression followed the same steps for 
RNA-sequencing data as described previously 53. Only uniquely mapped reads were 
included for downstream analysis. All rRNA, tRNA and snoRNA reads were 
discarded.   
Aggregate plots for codon periodicity were generated by aggregating read 
counts across annotated start codons on the plus strand of the human genome that 
have average PhostCons scores greater than 0.9 in the flanking 100 bp window. 
Only 5’ end position of each read is counted. For chimpanzee and rhesus macaque, 




3.3.2 Statistical analysis  
Gene expression data 
We performed a series of analyses that focused on detecting differential 
divergence between primates across molecular phenotypes using RNA-seq, 
Ribosome Profiling, and quantitative Mass Spectrometry data. Sequencing read 
counts for RNA-seq and ribosome profiling data are converted to log2 Reads Per 
Kilobase per Million mapped reads (RPKM) for each orthologous gene. To test 
gene expression differences in translational level between primate species, we 
adopted a nested linear model approach and computed a likelihood ratio statistic 
to quantify statistical significance of species differences in ribosome occupancy 
levels. To test species difference in translational divergence, we performed a joint 
analysis of RNA-seq and ribosome profiling data. We adopted a nested linear 
model approach, in which the likelihood ratio statistic quantifies the statistical 
significance of differences between species divergence at each molecular layer. 
Similarly, we performed joint analysis of ribosome profiling data and mass 
spectrometry data to test species differences in post translational divergence. Since 
protein expression level was measured by the SILAC labeling technique which 
computes a log2(sample /standard) ratio of peptide abundance for each individual 
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53. Ribosome profiling data were adjusted accordingly in the joint analysis to 
assimilate the quantitative range between data types.  
Subsampling for variance comparison 
Subsampling for variance comparisons was performed using the sample 
function in R 57. Background genes were classified by expression level into 20 
categories. The probability for each category to be drawn is proportional to the 
expression level distribution of the buffered genes. For each iteration, sampling is 
performed without replacement to avoid drawing the same gene twice.  
3.3.4 Functional enrichment analysis 
Enrichment analyses were performed as previously described in 53 with the 
following exceptions. Gene ontology analysis was performed using GOstats 58. For 
each gene list tested, the full set of 3188 quantified genes was used as the 
background list. To calculate the number of missense mutations for each gene we 
converted the human-chimpanzee coding sequence alignment fasta file (downloaded 
from UCSC genome browser, 2011) to a VCF file and used SnpEff 59 to annotate 
the functional consequences of each human chimpanzee substitution. We then used 
SnpSift and bedtools 60 to intersect and count number of missense mutations for 
each gene. For UTR PhastCons scores, we computed average scores for each 
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annotated UTR exons (downloaded form Ensembl, 2014) by averaging per base 
PhastCons scores from the 100-vertebrate alignment (downloaded from UCSC, 
date) using the UCSC tool bigWigAverageOverBed 61. For each gene, we identified 
the median value among the average PhastCons scores from all associated UTR 
exons as the representative PhastCons score for the 5’ and 3’ UTR, respectively. 
 
3.4 Results  
3.4.1 Ribosome profiling captures variations in protein translation among 
primates 
To compare levels of protein translation genome-wide in primates, we used 
high throughput sequencing technology to profile ribosome protected fragments of 
mRNA 7 in five lymphoblastoid cell lines for each of human, chimpanzee and 
rhesus macaque that we previously collected mRNA level and protein level 
measurement 53. After removing sequencing reads from rRNA and other 
contaminating sources, we obtained a median coverage of ~12 million uniquely 
mapped reads per sample. High sequencing quality and high technical replications 
for each cell line between sequencing runs was observed. Across all samples, we 
found median footprint length of 29 nt, and consistent codon periodicity patterns 
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among species (Figure 12a), both features indicative of footprints of elongating 
ribosomes.  
Ribosome occupancy level has previously been shown to be an effective 
approximation for the level of translation 54. We computed translational levels 
using normalized read counts for Ribosome Protected Fragments (RPF) that 
aligned to exons orthologous across the three primate species being studied 
(http://giladlab.uchicago.edu/orthoExon/). The major signal in the ribosome 
occupancy data is reflective of species differences (Figure 12b). As indicated in the 
results of Principal Component Analysis, we observed clear separation of the data 
points by species in the first two principal components. Interestingly, when 
ribosome profiling and RNA sequencing data are analyzed jointly, the data points 
are also separated by technology type (in addition to species) in the first two 
principal components (Figure 12c). This result highlights the fact that ribosome 
profiling captures biological signals different from those of an RNA sequencing 
experiment.  
Between human and chimpanzee, we found 1,700 genes differentially 
translated (likelihood ratio test at 1% FDR) out of 10,050 genes quantified by 
ribosome profiling. Significantly more genes are differentially translated between 
human and rhesus, at the same FDR cut-off (3,295 genes, p < .0001, Chi-squared 
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test). Similar results are observed between chimpanzee and rhesus. A higher 
number of differentially expressed genes is expected between human (or 
chimpanzee) and rhesus, given the greater evolutionary distance.  
Taken together, our analysis indicates that the major signal in the set of 
ribosome profiling data captures the essence of biological variations in translation 
amongst primate species.  
3.4.2 Variations in transcription across primates are mostly propagated to 
translation  
Previously we reported that the divergence of gene expression in mRNA 
level between human and chimpanzee is largely attenuated at the protein level 53. 
To gain a mechanistic understanding, we evaluated the relative contribution of 
translation. To do so, we analyzed ribosome profiling data in conjunction with 
RNA-seq and quantitative mass spectrometry data. We focus on a set of 3,188 
genes that are quantified across all three layers of molecular phenotype.  
Overall, strong correlation across genes is observed among mRNA level, 
translation level and protein level. While level of translation (ribosome occupancy) 
appear to correlate better with mRNA levels than with iBAQ estimates of protein 
levels, we reason that the difference could be driven by similarity in technology 
 
 55 
used to estimate mRNA and translation levels. To better account for technology 
differences and take advantage of the more quantitative estimate of protein level 
with SILAC labeling, we estimated relative expression levels by standardizing over 
a reference line (GM19238) for each type of the gene expression level estimates 
independently. We then compared correlation between data type per gene across 
species. Interestingly, in this comparison, we still found significantly higher 
correlation between mRNA and ribosome occupancy (median Spearman’s .38) 
comparing to between protein and mRNA (median Spearman’s .32) or between 
protein and ribosome occupancy (median Spearman’s .28) (Figure 13a). Higher 
correlation between mRNA and ribosome occupancy in this context indicates that 
for genes differentially expressed among species, translation levels tend to share 
more variation with transcript levels than with protein levels. Similarly, in a 
replication test across layers of molecular phenotypes for genes showing differential 
divergence between human and chimpanzee, we found higher replication rate 
between mRNA level divergence and ribosome occupancy level divergence (64%) 
than replication rates of either by protein level divergence (~45%).  
To further investigate this observation, we ask in general how correlated are 
the cross species divergence in translation levels and transcript levels. We found 
that between human and chimpanzee, divergence in transcript levels tends to 
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correlate well with the divergence in translation level (Spearman 𝜌 =    .5 among 
3,188 genes, Figure 13b). This correlation increased when only genes that are 
differentially expressed between human and chimpanzee at either transcriptional or 
translational layer were considered (Spearman 𝜌 =    .64), indicating a sizable 
dilution of the correlation by noise in the data. Similar results were seen within a 
larger set of 8,572 genes for which we have quantification for both RNA level and 
ribosome occupancy level. This observation is in contrast to previous observations 
on differences in divergence between RNA and protein levels 53, indicating that 
translational regulation is likely either less common or smaller in effect size than 
post-translational regulation between human and chimpanzee LCLs. 
To further substantiate this inference we compared the significance level 
between differential divergence for each of the transcript-ribosome occupancy level 
comparison and ribosome occupancy-protein level comparison (Figure 13c) and the 
effect size of differential divergence (Figure 13d). We found larger effect size (p < 
.0005, Wilcoxon Rank Sum) and more significant p values in ribosome occupancy-
protein level divergence. Both results support the inference of less regulation at the 
translational levels. We therefore conclude that in general translation tends to 
propagate variations in transcript levels with minor modulations.  
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3.4.3 Differences between RNA and protein level divergence across primates can 
partly be explained by translational regulation 
While translation in general propagates variations in transcript level, there 
is a subset of genes that show translation specific regulation. To evaluate the 
contribution of translational regulations to differential divergence between RNA 
and protein level across primates, we examined the divergence level of ribosome 
occupancy relative to mRNA and protein. We found that ribosome occupancy 
shows intermediate levels of divergence for genes that are differentially divergent 
between RNA and protein levels (Figure 14a-h). While we found more similarity 
between ribosome occupancy and RNA level divergence (Figure 14c, g), it is clear 
that translation contributes to some extent the differences in divergence at the 
protein level (Figure 14a, d, e, h). To further estimate the level of contribution, we 
calculated the replication rate of differences in protein level divergence from RNA 
by ribosome occupancy. We found that for genes that show enhanced divergence at 
the protein level, 31 % can be explained by an enhanced divergence at the 
ribosome occupancy level. Similarly, for genes that show attenuated divergence at 
the protein level, 24 % can be explained by attenuation at ribosome occupancy 
(likelihood ratio test, 1% FDR). Interestingly, for genes that show no significant 
differential divergence between RNA and protein levels (Figure 14i-l), some 
 
 58 
differential divergence is observed at ribosome occupancy levels when comparing to 
RNA divergence levels (Figure 14k). These differences are then attenuated post 
translationally (Figure 14l), indicating that certain regulation at the level of 
translation only lead to changes in turnover rate of the protein but not the steady 
state level. 
To formally test the differences specifically at the translation level (i.e. not 
propagated from transcript level), we developed a model that can be used for 
differential testing of translation efficiency −	 an estimate for the amount of 
translation per transcript as a function of the mRNA expression level. After taking 
into account the inherent variations at the mRNA level, we found 478 genes that 
show translation specific regulation out of 3,188 at 1% FDR. Of those 291 genes 
show translation-specific enhanced variation and 187 genes show attenuation of 
transcript level variation (Figure 15a).  
We next ask if there are common features shared by genes that are 
differentially regulated in translation between human and chimpanzee. We found 
these genes to have significantly lower GC content (p < 10-12, Wilcoxon rank sum) 
and more reported protein-protein interactions (p < 10-4, Wilcoxon rank sum) 
(Figure 15b) suggesting that sequence content in the coding region could play a 
role in functional regulation of differential translation. In addition, we found that 
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these genes tend to have longer 3’ UTR (p < .0002, Wilcoxon rank sum) and more 
predicted miRNA binding sites (p < .005, Wilcoxon rank sum) (Figure 15b). This 
observation is consistent with a role for regulatory elements in UTR regions in 
regulating translation. Interestingly, we also found that the UTR regions of these 
genes are more conserved across vertebrates (5’UTR, p < 0.005; 3’UTR, p < 
0.0005; Wilcoxon rank sum) (Figure 15b), which could indicate that the divergence 
in translational regulation may be specific to the primate lineage. Taken together, 
we observed primate specific translational regulations that could be mediated 
through differential miRNA binding in the 3’ UTR sequences.  
To further investigate the functional implications of translational regulation 
in primate evolution. We estimated the proportion of differential translational 
regulation between human and chimpanzee that gets percolated to the protein 
expression levels. We found that among 478 genes that show differential regulation 
at the level of translation (compare to the transcript level) at 1% FDR, only 79 
genes maintain the same direction of variation at the protein level. The majority 
showed no differential divergence between protein level and mRNA level (Figure 
15c). Intriguingly, when we categorize genes by direction of translational 
divergence, we found that translationally enhanced genes tend to have low 
percolation rate (8%) (Figure 15d) This is in sharp contrast to the 30% percolation 
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rate for translationally attenuated genes (Figure 15e). The estimated proportion of 
percolation varies with the significance cutoff choices due to power issues. However 
the asymmetry is robust to the cutoffs used for the differential divergence tests. It 
should be noted that here we are focusing on the extreme tails of the translational 
regulation distribution. Taken together with the analysis on the general 
distribution, these observations indicate that translational regulations may affect 
the turnover rate of proteins in addition to the steady state level. While 
translational enhancements of divergence mainly contribute to divergence in the 
protein turnover rate, translational attenuations of divergence contribute more to 
stabilizing protein levels. Interestingly, gene ontology analysis for genes that are 
translationally enhanced in divergence (divergent in protein turnover rates) (Figure 
15d) showed enrichment of genes involved in negative regulation of cAMP 
metabolism, cell division and translation. While in contrast, for genes that show 
translational attenuation of divergence (Figure 15d), we found enrichment of 
negative regulation of catabolic activity and response to chemical or cytokine. 
These results indicate that species divergence in protein turnover rate is likely 
reflecting species differences in signal transduction pathways. On the other hand, 
divergence attenuation by translational regulation likely reflects a mechanism 
maintaining homeostasis in response to environmental stimuli.  
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3.4.4 Variations in translation across primates are frequently attenuated in 
protein levels 
By jointly analyzing ribosome profiling data and mass spectrometry 
measurement of protein levels, we could estimate the contribution of 
posttranslational gene regulation to steady state protein levels. Between human 
and chimpanzee, we found 381 genes that are differentially divergent between 
translation level and protein level (FDR 1%), indicating significant post-
translational regulation on expression of these genes. More genes were attenuated 
at the protein level than enhanced (325 vs. 56, Fisher’s Test p < .005). This 
asymmetry indicates a prevalence of variation attenuation in posttranslational 
regulation of protein levels (Figure 16a). In fact, using a more relaxed significance 
cutoff (5% FDR), we found 1937 genes (out of 3188 genes quantified) to be 
significantly less divergent (fold difference between human and chimpanzee) at 
protein level than at the translational level. The observed prevalence of post-
translational attenuation of divergence is not simply reflecting an increase in 
technical noise in protein measurement. We have previously shown that technical 
variation in quantitative mass spectrometry data is actually smaller than 
sequencing data 53.  
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While the above analysis indicated a relatively strong contribution of post-
translational attenuation in gene regulation, it remains possible that fundamental 
differences in data distribution between the two data types could obscure the 
results. To address this issue, we coerced both data types into the same 
quantitative ranges and compared their effect sizes. We found similar patterns in 
divergence attenuation at the protein level reinforcing the conclusion that post-
translational attenuation should be considered a major gene regulation process 
contributing to human and chimpanzee gene expression differences. 
To further investigate the potential mechanisms that could account for this 
observed post-translational gene expression attenuation, we seek common features 
shared among genes in this group (1% FDR). Post-translational attenuation could 
result from protein sequence divergence between human and chimpanzee that led 
to differences in protein stability. However, we found no enrichment of non-
synonymous substitution between human and chimpanzee in the group of post-
translationally attenuated genes (Figure 16b). In contrast, we found enrichment of 
reported phosphorylation sites (p < .002, Wilcoxon rank sum) and ubiquitination 
sites (p < .003, Wilcoxon rank sum) after standardizing by protein length (Figure 
16b). Enrichment of known post-translational modification sites suggests that the 
attenuation of translational differences could be mediated through differential post-
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translational modification mechanisms between human and chimpanzee that 
buffers the variation in gene expression levels between species. In addition, we 
found that post-translationally buffered genes tend to be expressed in more tissues 
(p < .006, Wilcoxon rank sum) and have more reported protein-protein 
interactions (p < .0002, Wilcoxon rank sum) (Figure 16b), suggesting importance 
of post-translational buffering in multiple biological processes. We next ask if post-
translationally buffered genes are enriched for functions in certain biological 
processes. We found enrichment of mainly housekeeping functions such as 
translation, nucleic acid metabolic processing and protein targeting to ER (Figure 
16c). It appears that post-translational attenuation of species divergence in gene 
expression levels functions mainly in maintaining stable protein level for genes 
involved in fundamental biological processes. Unexpectedly, we found enrichment 
of associative learning and neuronal ontology terms for genes that are post-
translationally enhanced for the protein level divergence between human and 
chimpanzee. While it is interesting to speculate how protein level divergence driven 
by post-translational regulation could contribute to cognitive differences between 
human and chimpanzee, the observation made here are based on experiments 
performed using immortalized B cells. Although gene regulation modules are known 
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to be shared across tissue types 62,63, it remains unclear whether this enrichment 
would be replicated in neurons. 
3.4.5 Post-translational buffered genes are under stabilizing selection in protein 
level 
The observed post-translational buffering between human and chimpanzee 
pointed to a mechanism in placed to maintain stable protein expression levels 
across species. To ask if this buffering mechanism is conserved across primate 
linages, we ask if the buffered genes are under stabilizing selection at protein levels 
in primates. We found that buffered genes (1% FDR) are 2.36 times as likely to be 
under stabilizing selection as genes that are not buffered, when stabilizing selection 
is defined as the top 300 genes that have the lowest protein expression level 
variance among primates 53 (Figure 17a). This enrichment is not simply driven by a 
mean variance relationship, as the mean expression levels between buffered and 
non-buffered genes are comparable across all three species. Since the current 
framework for estimating stabilizing selection could suffer from issues resulted from 
significance cutoff selections, we choose to further examine the enrichment of 
buffered genes in the group of genes under stabilizing selection defined by various 
cutoffs (Figure 17a). It appears that even for top 1000 stabilizing selected genes, we 
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still observed a ~1.8 fold enrichment of buffered genes. A similar result is observed 
with a relaxed cutoff for defining the set of buffered genes. To further substantiate 
this conclusion, we identified buffered genes from each of the three pairwise species 
comparisons independently and then tested if the overlap is more then expected by 
chance. We found that around half of human-chimpanzee buffered genes are also 
buffered in human-rhesus comparison (p < 10-6). In addition, roughly a third of 
human-chimpanzee buffered genes are buffered in chimpanzee-rhesus comparison (p 
< 10-15) (Figure 17b). Significant overlaps across each group of buffered genes 
supports the conclusion that post-translational buffering of protein expression is 
likely a conserved mechanism.  
Since protein expression levels are likely the main relevant quantities for 
gene function, we expect that the presence of a post-translational buffering 
mechanism would permit relaxation of selection constraints on the transcript level. 
Consistent with this hypothesis, we found higher cross species variations in mRNA 
levels for buffered genes. This result, however, is harder to interpret given that 
ribosome occupancy and mRNA levels are highly correlated and here we are 
examining variations in mRNA levels across samples that are highly variable at the 
ribosome occupancy level to begin with. In addition, species divergence that are 
not buffered also contribute to variance in the background set, which leads to an 
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underestimate of differences in the variance level between buffered and background 
genes. To better test this hypothesis, we examine signs of constrained relaxation at 
mRNA levels in the context of recent human evolution. We compare variations at 
the mRNA levels in the Yoruba population 15 between buffered genes (identified 
across human and chimpanzee) and the background. We found slightly higher 
variance for buffered genes across individuals. This difference is significant (p < 
0.02) when the selected background set is adjusted according to expression levels of 
the buffered genes (Figure 16c) to account for the known mean-variance correlation 
in sequencing data 25,64. It appears that the buffered genes identified across human 
and chimpanzee have a relaxed constraint at the mRNA levels among the Yoruba 
individuals. We reason that high variation at the mRNA level in the population 
will allow us to identify more eQTL with greater effect size. Counter intuitively we 
found no apparent enrichment of eQTL among buffered genes and on average 
smaller effect size. Higher variation at mRNA expression levels accompanied by 
lower power in detecting eQTL indicates that there are more linked variants in the 
regulatory regions of buffered genes that are acting in opposite directions. This 
interpretation is in line with the hypothesized relaxation in selection constraint at 
the regulatory regions for buffered genes. Following the same line of logic we 
compared expression variations between lincRNA (functional molecule) and mRNA 
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(information intermediate) of matching expression levels. We found lower 
variations among individuals in lincRNAs relative to mRNA, supporting the idea 
of a general relaxation in selection constraint at the mRNA level. This observation 
supports the hypothesized general post-translational buffering mechanism acting in 
humans that stabilize the protein level despite variations upstream.   
 
3.6 Discussion 
To determine the contribution of translational regulation in gene expression 
level differences between human and chimpanzee, we generated new data using 
ribosome profiling to estimate translation levels. Close inspection of the features of 
ribosome protected fragments (sequencing reads) and global analysis on ribosome 
occupancy levels across species lead us to conclude that our data captures the 
footprints of translating ribosomes, which have been shown to be the closest 
measurement to approximate the level of translational activities 54. This dataset in 
conjunction with the data described in Battle et al. 55 and Cenik et al. 65 provides a 




Through joint analysis with RNA-seq measurement of transcript levels and 
quantitative mass spectrometry measurement of protein levels, we provided an 
integrated view of gene regulation. We found that variations at the transcript level 
tend to propagate to level of translation (ribosome occupancy), which suggests 
minor regulatory variations between human and chimpanzee that directly impact 
the level of translation. This observation is in contrast to previous reports on 
pervasive translational buffering observed in F1 hybrids between S. cerevisiae and 
S. paradoxus 21,66. Interestingly a report focusing on the same process in hybrids 
between laboratory and wild isolated strains of budding yeast 67 and a follow up 
reanalysis of the Artieri dataset 68 did not confirm the pervasive translational 
buffering. Instead, their results were more in line with our observation in primates. 
Scarcity in translational regulation differences between human and chimpanzee is 
unexpected, given the amount of substitutions present in the UTR regions. It is 
possible that these genetic variations are cryptic in the environment tested and 
response to perturbations could reveal species divergence in translational regulation 
69. 
While we observed general concordance between transcript level and 
ribosome occupancy level divergence between human and chimpanzee, we did find 
contributions of translational regulation to RNA-protein differential divergence 
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when focusing on extreme tails of the distribution. We found roughly a third of 
protein level divergence deviated from mRNA level could be replicated in ribosome 
profiling data at 1% FDR. Although the proportion replicated by translational 
regulation is determined by the choice of cutoff, it appears that the major force 
driving protein level divergence is downstream of translation. More surprisingly, 
among the limited number of genes that show differential regulation in translation, 
translational regulation appears to have minor impact on gene expression 
differences at the protein level. Only about 15% of the genes that show differential 
human-chimpanzee divergence between translation and transcription (signal of 
translational regulation) show the same direction of effect percolated to the protein 
level. The observed percolation rate is highly asymmetric. While close to 30% of 
translational attenuation percolated to a stable protein level, only about 8% of 
translationally enhanced divergence is percolated (1% FDR). Although potential 
power issues prevented us from obtaining a precise estimate for percentage of 
translational regulation that has persistent impact on steady state protein levels. It 
is clear that only a minor proportion of translationally enhanced divergence has 
impact on protein levels. While we do find enrichment of miRNA binding sites 
amongst the group of genes that are differentially regulated at the level of 
translation, which could potentially explain the mechanism for translational 
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divergence 70, the biological significance at this layer of regulation remains unclear. 
It is possible that differential turnover rate, instead of steady state protein levels, 
between human and chimpanzee in this group of genes has biological relevance. 
Consistent with this notion, we found enrichment of genes in the cAMP pathway, 
which is fundamental to signal transduction of cellular processes 71, from the group 
of genes that show translationally enhanced divergence. We speculate that the 
differential turnover rate of this group of genes could determine distinct features 
distinguishing human and chimpanzee. 
In sharp contrast, posttranslational gene regulation appeared to have a 
much broader impact on protein levels. We found that regulation at this layer tend 
to attenuate variations created upstream. At 5% FDR, we estimated that as much 
as 60% of genes are under regulation of this post-translational buffering. Although 
precise estimation of this proportion is technically challenging, it appears that post-
translational buffering is quite common in the system inspected. Pervasive 
buffering of transcriptional and translational variation of gene expression levels has 
broad implications, especially in the context of evolution. For most genes, protein 
executes the cellular function. Variations in gene expression that failed to percolate 
to protein level are therefore less likely to cause any organismal phenotype. In fact, 
we found evidence for relaxation of selection constrain on the regulation of mRNA 
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levels in YRI population for buffered genes identified between human and 
chimpanzee. It appears that further investigating this property in context of 
population genetics would likely to provide valuable insights on how selection 
might act on the regulatory variants associated with genes possess such properties. 
We found similarities between effects of the observed post-translational buffering 
on gene expression variation and HSP90 chaperone action on rectifying mis-folding 
caused by missense mutations 72,73. We speculate that similar to HSP90, post-
translational gene expression buffering could confer phenotypic robustness by 
stabilizing protein expression levels.  
We found that genes regulated by post-translational gene expression 
buffering between human and chimpanzee tend to also be under post-translational 
buffering between human and rhesus (and between chimpanzee and rhesus). This 
observation suggested that post-translational buffering is likely a mechanism 
evolved under stabilizing selection for protein levels in primates. It remains unclear 
how post-translational buffering is achieved. We found enrichment of reported 
post-translational modifications amongst this group of genes but no significant 
enrichment of coding substitutions. One interpretation of this observation would 
suggest that divergence in post-translational modification mechanisms, between 
human and chimpanzee, instead of divergence in the coding sequence drives the 
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buffering. This interpretation makes intuitive sense, since substitutions in the 
coding sequence that affects turn over rate could not serve as a regulatory 
buffering mechanism while post-translational modifications are usually reversible 
and regulatory. Further investigation to identify factors involved in maintaining 
this mechanism would provide insights to advance our understanding of both how 
natural selection acts on gene regulation and how to better predict gene expression 
levels given genetic variations. 
Taken together, our results provided the first integrative view on gene 
express variations across primates that allows a separation between translational 
and post translational events. We found extensive post translational buffering of 
gene expression variations that lead to a stable protein level across primate species. 
We propose a scenario where buffering evolved under stabilizing selection of 
protein levels that removes negative effects on organismal fitness from protein level 
variations and allows the transcript level to diverge for quick adaptation to 
environmental changes. Given the energy cost of translation 74, it remains puzzling 
to us that the stabilizing selection appears to act on post translational level instead 
of at the translational level. We reason that evolution of post translational 
buffering mechanism is probably the more parsimonious path and speculate a 
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trans-acting mechanism to achieve this pervasive buffering in a relatively short 
evolutionary time. 
 
3.7 Figures  
 
Figure 12. Ribosome profiling captures species differences in protein translation 
levels.  
(a) Aggregate plots of 5’ position from all sequence reads that fall in each 80 base 
pair window flanking conserved start codons for each species. (b) Heat map 
presenting Spearman’s rank correlations for ribosome occupancy levels between 
individuals. Species label for each individual is color coded at the top and the side 
of the plot. (c) Joint principal component analysis of ribosome profiling data and 
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RNA-seq data. The first two principal components contributed to a combined 39% 
of variance across individual samples. The amount of variance in each sample is 






Figure 13. Translation propagates majority of transcriptional divergence. 
(a) Frequency of gene-wise Spearman’s rank correlation coefficients for the pairwise 
association of the three data types. The median per gene correlation is labeled by 
the vertical line. (b) Correlation between human/chimp species difference at 
transcriptional and translational level of gene expression. Plotted for each gene is 
the estimated fold change (human/chimp) of log2 RPKM values of ribosome 
occupancy levels against transcript abundance. Each gray circle represents a gene, 
Density of data points plotted are color coded as indicated in the key. (c) 
Statistical significance value of post-translational divergence for each gene exceeds 
the significance value of translational divergence. For each gene, the estimated 
significance level of divergence is plotted against the expected significance level. 
Red represents translational divergence, and green indicates post-translational 
divergence. (d) Effect sizes of post-translational divergence are larger than the 
effect sizes of translational divergence. Box plots display absolute value of 
divergence effect size among genes that are at least 2-fold divergent between 




Figure 14. Translational regulations contribute to differences in human-chimpanzee 
divergence between protein and mRNA. 
(a, e, i) Density plots of log2 transformed absolute divergence between human and 
chimpanzee for each layer of molecular phenotype. (b~d, f~h, j~l) Scatter plots of 
mean log2 fold differences between human and chimpanzee for each data type 
specified. Each data point represents a gene. (a~d) Showing data from genes with 
absolute RNA divergence greater than absolute protein divergence at FDR 1%. 
(e~h) Showing data from genes with absolute protein divergence greater than 
absolute RNA divergence at FDR 1%. (i~l) Showing data from genes with no 
significant differences between absolute RNA divergence and absolute protein 




Figure 15. Translational divergence leads to stable protein level and divergent 
protein turnover rate. 
(a) Scatter plot of mean log2 fold differences between human and chimpanzee for 
mRNA and ribosome occupancy levels. Only genes that are differentially divergent 
at 1% FDR are shown. Each data point represents a gene and is colored by 
direction of effects. (b) Boxplots comparing enrichment of molecular features 
between genes that are shown in (a) and the background (all the remainder). (c) 
The same as (a), except that mean log2 protein divergence is shown on the Y-axis 
instead of ribosome occupancy. (d) Density plots of log2 transformed absolute 
divergence between human and chimpanzee for each layer of molecular phenotype 
for genes that show translational enhancement of gene expression. (e) The same as 






Figure 16. Post-translational gene expression buffering is prominent. 
(a) Scatter plot of mean log2 fold differences between human and chimpanzee for 
protein and ribosome occupancy levels. Each data point represents a gene and is 
colored by direction of differential divergence at 1% FDR. (b) Boxplots comparing 
enrichment of molecular features between genes that are buffered [orange in (a)] 
and the background [open circle and green in (a)]. (c) Heat map showing p-values 





































Figure 17. Post-translational gene expression buffering is conserved in primates. 
(a) Scatter plot showing odds for human-chimpanzee buffered gene to also be top 
stabilizing selected genes in primates. (b) Venn diagram showing overlaps of 
buffered genes at 1% FDR amongst human-chimpanzee, human-rhesus and rhesus-
chimpanzee comparisons out of total 3188 genes quantified (c) Top: density plot of 
standard deviations of mRNA levels from YRI individuals comparing between 
buffered genes (red) and 500 sets of subsampled background genes of matching 
expression levels (blue). Bottom: Box plot summarizing the median of each 
subsampled standard deviation distribution. The red dot labels the median of 
standard deviation of buffered genes. The empirical p-value represents the 
probability of observing a median standard deviation greater than or equal to the 




4 Mapping cell populations in flow cytometry data for cross-sample 




Flow cytometry (FCM) is a fluorescence-based single cell experimental 
technology that is routinely applied in biomedical research for identifying cellular 
biomarkers of normal physiological responses and abnormal disease states. While 
many computational methods have been developed that focus on identifying cell 
populations in individual FCM samples, very few have addressed how the identified 
cell populations can be matched across samples for comparative analysis. This 
Chapter presents FlowMap-FR, a novel method for cell population mapping across 
FCM samples. FlowMap-FR is based on the Friedman-Rafsky nonparametric 
statistic (FR statistic), which tests the equivalence of multivariate distributions. As 
applied to FCM data by FlowMap-FR, the FR statistic objectively quantifies the 
similarity between cell populations based on the shapes, sizes, and positions of 
fluorescence data distributions in the multi-dimensional feature space. To test and 
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evaluate the performance of FlowMap-FR, we simulated the kinds of biological and 
technical sample variations that are commonly observed in FCM data. The results 
show that FlowMap-FR is able to effectively identify equivalent cell populations 
between samples under scenarios of proportion differences and modest position 
shifts. As a statistical test, FlowMap-FR can be used to determine whether the 
expression of a cellular marker is statistically different between two cell 
populations, suggesting candidates for new cellular phenotypes by providing an 
objective statistical measure. In addition, FlowMap-FR can indicate situations in 
which inappropriate splitting or merging of cell populations has occurred during 
gating procedures. We compared the FR statistic with the symmetric version of 
Kullback-Leibler divergence measure used in a previous population matching 
method with both simulated and real data. The FR statistic outperforms the 
symmetric version of KL-distance in distinguishing equivalent from nonequivalent 
cell populations. FlowMap-FR was also employed as a distance metric to match 
cell populations delineated by manual gating across thirty FCM samples from a 
benchmark FlowCAP data set. An F-measure of .88 was obtained, indicating high 
precision and recall of the FR-based population matching results. FlowMap-FR has 
been implemented as a stand-alone R/Bioconductor package so that it can be 





As the most mature single cell analysis technology, flow cytometry (FCM) 
has been widely applied in the diagnosis and characterization of cancers, infectious 
diseases, neurological disorders, immune system diseases, and hematological 
disorders 75. In a typical FCM study, tens to thousands of blood or tissue samples 
are processed to quantify cellular characteristics (e.g., protein expression levels) in 
individual cells. A modern polychromatic flow cytometer can measure up to 27 
cellular characteristics for millions of cells in each sample 76. To characterize and 
differentiate FCM samples from different experimental conditions/perturbations, 
cell populations need to be identified and their variations across samples need to be 
quantified and assessed. For example, regulatory T cells are known to suppress a 
variety of pathological and physiological immune responses. In peripheral blood of 
individuals with autoimmune disease, regulatory T cells tend to exist in smaller 
proportions than in healthy controls 77. Cell populations may also differ because of 
an individual's inherited biological traits. For example, immunoglobulin E (IgE) is 
an antibody that is elevated when the immune system overreacts to environmental 
allergens, such as pollen. In individuals that are predisposed to allergic responses, 
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elevated numbers of circulating B cells expressing the high affinity IgE receptor 
(CD23) can be found 78.  
Historically, manual gating has been used as the methodology of choice to 
delineate cell populations sharing common characteristics in FCM data. This 
graphically driven approach relies on the sequential application of manually drawn 
boundaries (i.e., gates) to distinguish cells on uni- or bi-axial data plots. The 
placement of manual gating boundaries is subjective and depends on the experience 
of the data analyst. In recent years, computational gating methods have made 
significant advances in identifying cell populations at the individual sample level 79. 
Model-based computational gating approaches, such as Gaussian and multivariate 
skew-t mixture model fitting 80–82, employ statistical assumptions on the shape and 
location of cell population distributions. Non-model based methods, such as grid-
based density clustering 83 and spectral clustering 84 algorithms, group cells into 
homogeneous populations based on unsupervised data clustering. 
After cell populations are identified in individual samples, the next step is 
to map cell populations between samples so that cell population characteristics, 
such as marker expression levels and proportions, can be compared across the 
sample set. In manual gating approaches, the gating boundaries drawn on one 
sample are often directly applied to another sample. However, marker expression 
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levels of equivalent cell populations can shift between different samples due to 
technical artifacts and natural biological variability. Technical artifacts can be 
unintentionally introduced during data acquisition, especially in multicenter clinical 
studies where samples are prepared at several sites, with slight differences in 
sample preparation procedures, staining protocols, and instrument settings. 
Biological variability in marker expression can occur due to the complex interplay 
of genome sequence polymorphisms, especially in outbred human populations. 
Indeed, the effects of technical artifacts and biological variation can be difficult to 
distinguish. These inherent sources of variability in marker expression make the 
cell population mapping step using direct application of manual gating boundaries 
problematic for cross-sample comparisons. 
To our knowledge, there is no stand-alone method implementation focused 
solely on cell population matching. Probability binning 85 is able to compare 
multivariate distributions between FCM samples but it remains unclear how it can 
be adapted to compare population-level data as cell populations frequently shift 
expression distributions across samples. Finak et al. 86 compared sample level 
variability in cell population marker expression among fluorescent channel 
transformation methods (e.g., bi-exponential or generalized Box-Cox). Variation 
between cell population locations is defined as the sum of squared deviations in the 
 
 85 
cell population locations (mean marker expression levels) across FCM samples. 
Small inter-sample variations in cell population locations are associated with low 
population misclassification rates.  
Other existing approaches, including FLAME 80, HDPGMM 82, JCM 81, and 
flowMatch 87 bundle the cell population identification method and cross-sample 
mapping function together, with the mapping component operating under the 
principle of global template finding. In FLAME 80, mapping cell populations across 
samples is the last step of their computational gating method. Each sample is 
modeled as a mixture of cell populations, each with a multivariate skew-t 
distribution. The modes of cell population distributions are pooled together across 
samples to establish a global template of cell populations, marked by their mode 
locations. The sample cell populations are then matched to the global populations 
based on the respective mode locations. In both HDPGMM 82 and JCM 81, a 
multilevel modeling approach is applied to simultaneously identify cell populations 
and map populations across samples. A global template is generated based on 
shared location and shape characteristics among cell populations across samples in 
the same cohort. JCM ascribes multivariate skew-t distributions to the cell 
populations as in FLAME, while the HDPGMM assumes Gaussian distributions for 
the cell populations. Both methods perform the mapping step automatically while 
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the population is being identified, which precludes their implementation with other 
data clustering methods. When a new sample is added to the data set, HDPGMM 
needs to be re-run on all samples to generate a new hierarchy that could be 
different from the original one even for the same sample. JCM directly compares 
the new sample with the population location and shape parameters at the cohort-
level using the Kullback-Leibler divergence measure (KL distance).  
In flowMatch 87, samples are organized into a hierarchy based on overall 
shape similarity between sample cell populations. The KL distance is also used to 
quantify the multivariate similarity between cell populations. Two samples are 
merged together under the hierarchy when the total between-sample KL distance is 
minimized. The root of the hierarchy is the global template of cell populations. 
These existing methods all require the composition of a global template, which can 
be error-prone without careful selections of mapping thresholds at each comparison. 
The construction of the template is also very sensitive to the clustering or gating 
procedures. Some of these methods do not calculate the degree of similarity 
between cell populations, limiting the ability to map heterogeneous cell populations 
across samples.  
Here we describe a novel method, FlowMap-FR, that uses a data-driven 
approach for cell population mapping. FlowMap-FR directly compares cell 
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populations between samples using the Friedman-Rafsky (FR) test statistic (FR 
statistic, 88) – a nonparametric multivariate statistical measure utilizing a minimum 
spanning tree approach to describe the “ordering” of values in multidimensional 
space. The FR statistic has been used as a similarity measure in statistical pattern 
recognition 89, image retrieval 90, and image registration 91. The basic principle is to 
“sort” the events from any two merged cell populations (e.g. cell populations in 
different samples being tested to determine if they are equivalent) based on edge 
connections in a minimum spanning tree constructed from the marker expression 
levels of each cell. The cell populations being compared are considered to be 
equivalent if their respective member events are randomly dispersed in the tree, 
and are different if the events of the same membership tend to congregate in 
different branches of the tree. Thus, FlowMap-FR evaluates cell population 
similarity by computing a statistical distance measure for every possible population 
pair in a cross-sample mapping problem. 
FlowMap-FR is a stand-alone method that can be applied to mapping cell 
populations delineated by manual gating or computational clustering procedures.  
We evaluated the performance of FlowMap-FR in simulation experiments designed 
to mimic commonly observed scenarios of sample variability for mapping cell 
populations in which differences in cell population proportions occur between 
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samples, slight differences in marker expression levels in equivalent populations 
occur between samples, and a cell population in one sample is inappropriately 
divided into two by over-partitioning in comparison with another sample. We also 
compared the performance of FlowMap-FR with the symmetric version of KL 
distance used in flowMatch 87 using both simulated and real data, and applied it to 
match gated populations from a FlowCAP benchmark data set [5]. 
  
4. 3 Methods 
4.3.1 Terminology 
In a given FCM experiment, the levels of a number of different quantitative 
markers (features) are measured in individual cells. Each cell can then be 
represented as a feature vector of marker levels in d-dimensional space. A cell 
population is defined as a homogenous group of cells sharing similar quantitative 
levels for all markers measured, and can be delineated by manual or computational 
gating methods as a feature vector cluster in multidimensional space. The number 
of features evaluated in the FCM experiment is equivalent to the number of 
dimensions of the multivariate vector. When comparing two cell populations, the 
events from the different populations can be combined to form pooled data. A 
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graph can be constructed on the pooled data, where the nodes represent the cell 
events and the edges represent the Euclidean distance between the multivariate 
feature vectors.  
4.3.2 Overview of FlowMap-FR 
 Figure 18 shows a hypothetical FCM assay of 4 expression markers (CD4, 
CD45RA, SLP76, ZAP70) for two different biological samples. The goal of cross 
sample comparison is to determine if either Cell Population (CP)red or CPgreen in 
sample B is equivalent to the CPblue reference cell population in sample A. The 
bi-axial plots indicate similarity between CPblue and CPgreen in all expression 
marker levels except for CD4, while CPblue and CPred are similar in all markers 
and would therefor be considered to be equivalent. The goal of any quantitative 
method for cross sample comparison would be to accomplish cell population 
mapping by objectively making this distinction using cell populations delineated by 
any data transformation procedure or gating method, including manual gating or 
algorithmic clustering.  
The FlowMap-FR method for cross sample mapping described here utilizes 
the Friedman-Rafsky multivariate generalization of the Wald-Wolfowitz run 
statistic for comparing two data distributions to determine if they have been 
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sampled from the same global data population. Wald and Wolfowitz 92 described a 
statistical procedure to compare univariate non-parametric distributions by 
merging the values from two different data sets into an ordered list and 
quantifying the number of runs that connect values derived from the same data 
set. The number of runs is thus associated with the tendency of the values to 
cluster together according to their respective membership in the data sets. A small 
number of runs connecting values from the same data set suggests that the values 
have been sampled from more than one distribution. Friedman and Rafsky 88 
proposed a generalization of this approach for multivariate data in which value 
order is determined based on proximity in a minimum spanning tree constructed in 
multivariate space.  
The basic idea is to connect the events across the two cell populations to be 
compared according to their similarity in expression of all d markers using a 
minimum spanning tree. The individual cell events are represented as nodes on the 
tree. The distance between two nodes is calculated as the Euclidean distance in d-
dimensional space. The FR statistic quantifies the multivariate similarity of nodes 
from any two underlying distributions in the minimum spanning tree (MST). The 
FR statistic also controls for the size of the MST across comparisons and the 
topological structure of the MST. We calculate the FR statistic comparing each 
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pair of cell populations. For example, a comparison of two biological samples with 
n1 and n2 cell populations would involve n1n2 total comparisons.  
FlowMap-FR estimates the FR statistic based on controlled statistical 
sampling of the events in data pooled from the two cell populations being 
compared. Each controlled statistical sample taken from this pool is comprised of 
events sampled to be proportional to those in the original cell population pair 
(above some minimum number of events). This controlled statistical sampling 
approach is employed because the computing time for calculating a minimum 
spanning tree is dependent on the number of nodes, that is, total number of events 
involved in a cell population comparison pair.  
Finding the Minimum Spanning Tree   
We begin by mixing events from two cell populations under comparison 
while keeping track of their population membership. The mixture of events is 
henceforth referred to as the pooled data. We then take S controlled statistical 
samples of N events randomly selected from the pooled data, without replacement. 
Each controlled sample maintains a constant ratio of events from the two cell 
populations, calculated from the pooled data before any event selection. For every 
controlled statistical sample, we compute the Euclidean distance between every 
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pair of events based on the expression level of all markers. A complete weighted 
undirected graph is constructed based on the N-by-N distance matrix. We then use 
Prim’s algorithm [21,22] to find the minimum spanning tree (MST) on the graph. 
The distance between events on the minimum spanning tree corresponds to the 
dissimilarity of their marker expressions in d-dimensional space. Therefore, events 
with similar marker expression levels are placed near each other on the MST 
branches.  
Friedman-Rafsky Statistic Computation 
Central to the Friedman-Rafsky (FR) statistic are the multivariate “runs” 
in the Euclidean MST. The multivariate runs are the set of subtrees in the MST 
consisting of connected events from a single cell population. For each controlled 
sample MST based on N events, we remove the edges connecting events derived 
from different cell populations. Because any removal of an edge in an MST breaks 
the tree into two disjoint subtrees, the number of subtrees in an MST is equal to 
the number of removed edges (G) plus 1. Thus, the number of multivariate “runs” 
𝑅 is equal to 𝐺 + 1.  
The FR statistic compares the observed with the expected number of 
multivariate runs in a given MST from two equivalent population distributions, 
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then standardizes the difference by the variance of the multivariate runs. Given 
two cell populations 𝑋 and 𝑌 of event sizes m and n, respectively, with 𝑁 total 
events, the expected number of multivariate runs 𝔼[𝑅] is equal to one plus the 
expected number of edges. For the 𝑁 − 1 edges of the given MST, the probability 
that an arbitrarily selected edge connecting 𝑋 and 𝑌 (or 𝑌 and 𝑋) is the proportion 
of events in 𝑁 belonging to 𝑋, 𝑚/𝑁 (or 𝑛/𝑁 if considering edges connecting 𝑌 
and  𝑋) multiplied by the probability that the edge connects to a node in 𝑌 (i.e., 
𝑛/(𝑁 − 1) or  𝑚/(𝑁 − 1) if considering 𝑌 − 𝑋 edges). Hence, the expected number 
of edges is  
𝜇 = 𝐸 𝑅 =
2𝑚𝑛
𝑁 + 1   
The variance of the number of runs in a given MST is dependent on the 
corresponding topological feature – the total number of edge pairs sharing common 
nodes  (𝐶), which is !!!!  in a graph of N nodes. Hence, the variance reflects the 
range of runs possible given the composition of membership events in a cell 






𝐶 − 𝑁 + 2 𝑚 + 𝑁 𝑁 − 1 − 4𝑚𝑛 + 2
𝑁 − 2 𝑁 − 3 . 
Details of the derivation can be found in Friedman and Rafsky 88. The FR statistic 






The median FR statistic from the S controlled statistical samples of the 
pooled data is taken as the estimated measure for similarity between the two cell 
populations. The estimated FR statistic is multiplied by −1 to compute an FR-
based distance measure, where a small value indicates high degree of similarity and 
a large value indicates high degree of dissimilarity. This FR-based distance 
measure can then be used with various clustering methods to group cell 
populations across samples (e.g., by hierarchical clustering).  
Hypothesis testing using the FR statistic  
We can also use the estimated FR statistic to perform a statistical test 
where the null hypothesis is that the two cell populations follow the same 
distribution. The p-value of the FR statistical test is computed under the 
assumption that the standardized FR statistic follows a normal distribution 88. A 
large p-value is evidence that the cell populations in the comparison are probably 
similar in their distributions, while a small p-value is evidence that the cell 
populations are probably different in their distributions. In addition to cell 
population similarity, the p-value of the FR statistic also depends on the number 
of controlled statistical samples of the pooled data  (𝑆) and the size of each 
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controlled sample  (𝑁). For the analyses in the current study, we chose a value of 
10-7 for the p-value threshold of the FR statistic where the number of true positive 
matched cell population pairs is maximized and the number of false positive cell 
population pairs is minimized. The threshold was chosen based on sampling 
parameters  𝑁 =  200 and 𝑆 =  200. Details of choosing the sampling parameters are 
described in the following section.  
Sampling Parameters 
In order to both reduce runtime and provide for consistent statistics, data 
sampling is necessary before the FR statistic is applied. With the controlled 
sampling approach, the FR statistic value in a pairwise comparison between two 
cell populations depends on the number of controlled samples  (𝑆), and the number 
of events in the pooled controlled sample  (𝑁). We assessed the precision (reflecting 
the extent of reproducibility of the controlled sampling procedure) and accuracy 
(indicating the biasedness of the estimated statistic as a function of the sampling 
procedure) of the FR statistic under 𝑁 = 100, 200, 400 and 𝑆 = 100, 200, 400. 
While increasing 𝑆 results in a larger range of the FR statistics, the ranks of the 
population pairs remain the same, and the FR statistic value increases as 𝑁 
increases. Nonetheless, when mapping cell populations across two samples, the 
ranks of the population comparisons remain the same across varying 𝑁 and 𝑆. The 
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time complexity of the controlled sampling approach is assessed under 𝑁 = 50, 
100, 200, 400, 600, 800, and 1000 and 𝑆 = 100, 200, and 400. The time complexity 
increased quadratically in the number of the events, but did not change across the 
number of controlled samples. FlowMap-FR computes an adjacency matrix of 
similarity between 𝑁 events based on Euclidean distance between the d-
dimensional measurement vectors. Prim’s algorithm is then employed to find the 
MST of each controlled sample. The computing time of MST finding is known to 
increase quadratically in 𝑁 in the Prim’s algorithm when the similarity between 
the events are represented in an adjacency matrix. In summary, 𝑁 and 𝑆 are 
chosen to preserve the ranks of the FR statistics with balanced precision and 
accuracy as well as minimized computing time of MST. 
Data preprocessing 
FlowMap-FR is designed as a stand-alone algorithm that can be applied to 
mapping cell populations derived from any gating procedures or any normalization 
methods. The input data contains ASCII files with each cell population’s labels and 
marker expression levels derived from manual gating or automated gating method. 
Before applying FlowMap-FR, the user needs to choose a transformation method 
to transform the raw data into equivalent quantitative ranges based on their data 
formats and use cases. We employed FCSTrans 95 for all the analyses in this paper.  
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4.3.3   Simulation study 
Design 
In order to assess the performance of FlowMap-FR under a variety of 
different population mapping scenarios, a simulated data set was constructed to 
closely mimic real FCM data. Data from FCM experimental samples vary in 
distributional shape depending on the sample’s biological characteristics. In order 
to conduct a fair performance evaluation of our cell population mapping method, 
we sought to mimic possible sources of experimental sample variability in cell 
population characteristics. We selected a real data set that includes cell 
populations possessing features inherent to FCM data: sparseness of some 
populations but not others, skewness in the distribution of some cell population 
markers, high correlation between expression levels for a subset of markers, and 
flat density distributions for some markers. The real data were derived from an 
FCM experiment in which human peripheral blood was assayed with a four marker 
panel: CD14, CD23, CD3, and CD19 96. The FLOCK clustering algorithm 83 was 
used to identify nine distinct cell populations (CP1:CP9) in an FCS data file from 
one sample totaling 20,000 events.  
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Multivariate skew-t distributions were employed to extract location, 
variance and skewness parameters of each cell population in the real data. The 
estimated parameters of the fitted skew-t distribution were then used to simulate a 
new data set that mimics the marker distributions observed for each reference cell 
population. Figure 19A and Figure 19B show cell population distributions for 
selected markers in the real sample and in the simulated sample, respectively. An 
important FCM data feature is that some cell populations may overlap in some 
marker channels while being well separated in other dimensions. This can be 
illustrated by CP3 and CP9. Their marker expression levels are overlapping and 
correlated in the two-dimensional scatter of CD23 and CD14 and also between 
CD3 and CD14. However, they are well separated based on CD19 marker 
expression levels.  
Evaluation Scenarios  
In FCM data, cell populations may exhibit slight shifts in marker levels 
between biological samples or vary in the percent composition per sample between 
individuals or cohorts (i.e., varying proportions). The simulated data set was used 
to construct a series of test samples designed to mimic these real scenarios in cross 
sample comparison challenges to test the cell population mapping performance of 
FlowMap-FR, as follows: 
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Scenario 1. Differences in cell population proportions between biological samples 
(Figure 19C). Test samples were constructed in which cell proportions were 
changed to 1%, 10%, 25%, 50%, 75%, 125% and 150% of the original simulated cell 
population. Location and shape of the changed cell populations was maintained as 
in the original simulated cell populations. Each changed cell population was a 
statistical sample of events randomly generated with the same location and shape 
parameters as the original simulated cell population.  
Scenario 2. Differences in cell population numbers between biological samples. Test 
samples were constructed in which one of the simulated cell populations from one 
biological sample was removed. The resulting test sample containing eight cell 
populations was compared with the original simulated sample containing nine cell 
populations.  
Scenario 3. Shifts in marker expression levels between biological samples (Figure 
19D). Test samples were constructed in which the simulated cell population from 
one biological sample is shifted along each marker channel one at a time. The unit 
of location shift is standardized for each cell population and defined as the 
interquartile range (𝐼𝑄𝑅!,!) of the original simulated cell population along channel 
𝑖, where 𝐼𝑄𝑅!,! = 75th percentile – 25th percentile of the original simulated cell 
population in channel 𝑖. For each of the nine cell populations, we simulated 1, 2, 3, 
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4 and 5 𝐼𝑄𝑅!,! shifts along each marker channel. Denote 𝜇!,! as the original location 
of a cell population along channel  𝑖 and 𝜇!,! as the shifted location after 2 units of 
interquartile range shift. Then, 𝜇!,! =   𝜇!,! + 2 ∗ 𝐼𝑄𝑅!,!.  
Scenario 4. A discrete cell population in the reference sample inappropriately 
divided into two in the test sample by over-partitioning (Figure 19E). Test samples 
were constructed in which the single simulated cell populations from the reference 
sample were divided into two partitions along the CD23 channel. Two sets of 
partition samples were simulated accordingly, that include the upper and lower 
partitions above and below the 90th, 80th, 70th, 60th, 50th, 40th, 30th, 20th, and 10th 
percentile of the corresponding CD23 levels.  
4.3.3.3    Comparison with the Kullback-Leibler Divergence Measure 
The results using the simulated scenarios was also evaluated using the 
symmetric version of Kullback-Leibler (referred to be SKL distance to distinguish 
from the original KL distance) divergence measure used in flowMatch to compare 
cell populations across multiple samples 87. The KL distance is known as an 
asymmetric distance measure between two distributions such that the values 
comparing CP1 to CP2 and CP2 to CP1 can differ. In flowMatch, a symmetric 
version of the KL distance (SKL) is employed under which the cell populations are 
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assumed to follow multivariate normal distributions. Using this version, the KL 
distance is a function of means and variances of the cell populations. The SKL 
distance is achieved by averaging of the two possible KL values in a single 
comparison. Given two cell populations i and j in d-dimensional feature space, the 
KL value of comparing i against j is:  
1
2    log
Σ!
|Σ!|
+ 𝑇𝑟 Σ!!!Σ! + 𝜇! − 𝜇!
!Σ!!! 𝜇! − 𝜇! − 𝑑 , 
where 𝜇! and 𝜇!are d-dimensional mean vectors of the expression markers of cell 
populations i and j, respectively, and Σ! and Σ!   are d-dimensional variance-
covariance matrices of the markers for cell populations i and j, respectively. We 
computed sample means and variances to approximate 𝜇′𝑠 and Σ!𝑠  to calculate the 
SKL distance values of the simulated cell populations as in the flowMatch 
implementation. 
4.3.4 Real flow cytometry samples  
FlowMap-FR was applied to two real flow cytometry data sets to evaluate 
its performance in mapping cell populations across multiple real flow cytometry 
samples. The first evaluation investigated the ability of FlowMap-FR to map cell 
populations that are known to be biological replicates across FCM samples. The 
second evaluation applied FlowMap-FR to FCM samples collected from thirty 
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different healthy individuals. In this data set the individual cell populations within 
each sample and their equivalence between samples were delineated by expert 
manual gating as part of the FlowCAP challenges 79.   
Real FCM data set #1. The first real data set evaluation included four FCM 
samples of peripheral blood mononuclear cells (PBMC) collected from two healthy 
individuals 97; the blood sample from each individual was divided into two 
biological replicates. Each sample was stained with four fluorophore-labeled 
antibodies (marker panel: CD3, CD4, CD8, and CD19). Four cell populations were 
identified in each of the FCM samples using K-means clustering (parameter 
setting: minimum 4 and maximum 20 clusters). The K-means convergence criteria 
were set to minimize within-cluster sum of squares while maximizing between-
cluster sum of squares. In order to perform cell population mapping across multiple 
samples, we computed the estimated FR statistics and FR-based distance metric 
(FR multiplied by minus one) for all population pairs across the four FCM 
samples. The FR-based distances were used as a similarity measure to group and 
map equivalent cell populations across samples. Hierarchical clustering with 
complete linkage was employed as the clustering method of choice. The cell 
populations were arranged in a hierarchy according to the FR distance to the other 
cell populations.  
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The FR-based mapping approach was compared to flowMatch 87. flowMatch 
performs agglomerative clustering that repeatedly merges samples to form a 
template sample until there are no more samples to be added (meta-clustering). 
First, a template sample is created from merging the two most similar samples, 
and the matched cell populations are combined to form a cell population. Then, a 
template sample is compared to all the other samples and merged with the sample 
that is most similar. This step continues until there are no more samples to be 
compared with. At each step, cell populations are mapped across samples when the 
two samples are merged into one template sample. A bipartite graph algorithm is 
employed to match two samples or to match a sample with a template sample 
when the sum of distances between cell populations is minimized. The performance 
of the FR statistic was compared with the SKL divergence metric within the 
flowMatch algorithm.  
Real FCM data set #2: This normal donor data set was one of the benchmark data 
sets included as part of the FlowCAP-I challenge 79 and contains manually gated 
cell populations that can be used as a benchmark for evaluating the performance of 
FlowMap-FR. A total of thirty FCM samples from normal healthy donors are 
included in the data set. Each sample was stained with a cocktail of ten 
fluorochrome reagents, interrogating both cell surface and intracellular proteins. 
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Expert manual gating by the data providers delineated 8 cell populations in each 
sample. To perform cell population mapping across multiple samples, we computed 
the estimated FR statistics for all population pairs across the thirty FCM samples 
(28,680 comparisons). Similar to real data set #1, hierarchical clustering with 
complete linkage was employed in order to organize the cell populations in a 
hierarchy according to FR distance. Based on the FR similarity hierarchy, cell 
populations were classified into eight sets of equivalent cell populations. The F-
measure approach was then used to evaluate the combined precision and recall 
performance of the new cell population labels in comparison with the cross sample 
equivalence determined by the original data providers. 
 
4.4 Results 
4.4.1 Simulation study 
Matching with differences in cell population proportions between samples. 
The goal of cross-sample comparison is to match equivalent cell populations 
across multiple samples. In some circumstances, a given cell population can exhibit 
dramatic differences in proportions in different biological samples, especially cell 
populations that have been observed to be predictive cellular biomarkers of 
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immunological responses, disease states or therapeutic responses. In order to 
determine how robust the FR statistic would be to matching cell populations in 
scenarios in which the proportions of the population differ between biological 
samples, a total of eight test samples were generated to contain from 1% to 150% 
of the population’s cell count in the original simulated reference sample for each of 
the nine cell populations separately. The original cell counts ranged from 324 
events in CP9 to 7,380 events in CP7. Thus, in the case of CP9, the 1% proportion 
simulation contained as few as 3 events to be matched to the original cell 
population’s 324 events. For CP7, the 150% proportion simulation contained over 
11,000 events to be matched.  
Figure 20A - I shows the estimated FR statistics for each population 
comparison. An FR value closer to zero indicates a higher degree of similarity 
between the cell populations being compared. Figure 20A shows the comparison 
across changing proportions of CP1. The changed CP1 in the test sample is 
consistently rated as more similar to the equivalent CP1 population in the 
reference sample than to the other cell populations, even when the proportion of 
CP1 in the test sample is 1% of the equivalent cell population in the reference 
sample. The results are similar for all cell populations. Given a selected cell 
population comparison, the FR statistics are fairly stable across changed 
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proportions. The situations in which the differences in the FR statistics between 
correctly matched and incorrectly matched populations are the smallest appear to 
occur when comparing the most rare populations (CP3 and CP9) with the most 
abundant population (CP7) (Figure 20C and Figure 20I, respectively). But even in 
these situations, differences of approximately 3 FR units are observed between 
correct and incorrect matching, with the correct mapping still rated as most similar 
based on the FR statistic. We also computed the p-values of the FR statistics for 
each population comparison. A small p-value of the FR statistic indicates a 
potential mismatched pair of cell populations, while a large p-value of the FR 
statistic suggests a potential matched pair of cell populations. The cutoff for p-
value was fixed across all three simulation scenarios to be 10-7. Similar to the 
results using the FR statistics, the p-values also distinguish between correctly 
matched and incorrectly matched populations. At p-value cutoff of 10-7, the FR 
test correctly matches the changed cell populations to their equivalent parent cell 
populations in the reference sample.   
We also compared cell populations across the test samples of CP5 changed 
proportions to demonstrate the utility of FR statistic in a multiple-sample 
comparison scenario. In Figure 20J, a total of 72 x 72 FR statistics are displayed in 
a heat map (comparing 8 test samples of 9 cell populations) and listed in order of 
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population proportions within each cell population block (e.g., CP5 block consists 
of 1% (#1.5), 10% (#2.5), 25% (#3.5), 50% (#4.5), 75% (#5.5), 100% (#6.5), 
125% (#7.5), and 150% (#8.5)) The cell populations that were not changed in 
proportions are mapped to each other (i.e., FR statistics closer to zero) as 
expected. Although the 1% CP5 (#1.5) is slightly more similar to the other cell 
populations compared to the other changed CP5s, the 1% CP5 is still ranked as 
more similar to other CP5s under changed proportions than to any other cell 
population.  
Matching with differences in cell population numbers between samples. 
In some cross-sample comparison scenarios, differences in the numbers of 
cell populations detected in different samples might be expected. This could occur 
when comparing samples from normal healthy subjects with samples from diseased 
subjects in which a new abnormal cell population might be present (e.g. in 
leukemia or lymphoma patients, or in situations where stimulated and 
unstimulated samples are compared). Figure 20A - I show the estimated FR 
statistics for each population comparison. In this scenario there would be no 
comparison for one of the cell populations (e.g. CP1) in the reference sample since 
that population has been removed from the test sample. Because the comparison 
performed by FlowMap-FR occurs on a population-by-population basis, the FR 
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statistic values for comparisons between the incorrect cell populations in the test 
sample and the extra population in the reference sample is essentially the same as 
if the extra population was still present in the test sample. Thus, for a missing CP1 
population, all FR statistics values would correspond to a run value of 1 and the 
curves would be located at the bottom of the graph in the comparison depicted in 
Figure 20A. While all of the correct pairwise comparisons would give FR statistic 
values close to 0 for eight out of eight comparisons, the extra population would 
only give low FR values (e.g. < -10 in most cases), similar to what is observed for 
incorrect comparisons. Thus, establishing a lower threshold of ~ -5 would indicate 
that any population without a value above -5 would indicate a unique population 
in one of the samples. 
Matching with shifts in marker expression levels between samples. 
Shifts in marker expression between cell populations across a set of 
experimental samples can occur due to natural biological variability in genetically 
diverse populations, cell differentiation response to some perturbation, or technical 
variability associated with differences in staining procedures or reagent lots. In 
order to determine how the FR statistic would respond to shifts in marker 
expression, the nine cell populations were mapped to themselves and other cell 
populations in simulated scenarios in which one population (CP4) was shifted in 
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position along each of the four dimensions. Shifting was standardized with respect 
to the range (IQR) of the cell populations’ distributions along the selected 
dimension. A total of 6 test samples were generated with shifting positions along 
each dimension. The results of CP4 mapping are shown in Figure 21. The 
distribution of CP4 is narrow along CD19 and is wide along the other three 
dimensions. As the position shift increases along CD19 (with the distribution in all 
three other dimensions kept the same), the FR statistic for matching with the 
original CP4 initially drops linearly with the degree of shifting and then plateaus 
(Figure 21A). Thus, FlowMap-FR could be used to determine statistically 
meaningful shifts in marker expression within a cell population.  
In some cases, the shifted cell populations can also become more similar to 
other cell populations than to the corresponding population in the reference sample 
depending on the marker expression characteristics of the other populations. When 
CP4 is at a 2-IQR unit shift away from the original position in the CD19 
dimension, the FR value in comparison with itself in the reference sample is about 
-10 (Figure 21A) and with CP5 is about -6 (Figure 21B). This indicates that CP4 
in the test sample has become more similar to CP5 in the reference sample at a 2-
unit shift. Indeed, the distribution of CP4 in the CD19 and CD23 dimensions 
overlaps closely with CP5 at a 2-unit shift (see the scatter plots in Figure 21B). 
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However, even when substantial overlap was achieved between the shifted CP4 and 
the original CP5 at a 2-unit shift along the CD19 dimension, the FR statistic was 
still below -5 due to differences in distributions between CP4 and CP5 in other 
dimensions. Similar observations were made for CP8 (Figure 21C), which also 
overlaps with CP4 at 2-unit shifts in the scatter plots. However, the comparison of 
CP8 with the shifted CP4 produced only a modest increase in the FR statistics to -
11 since CP8 and CP4 are still quite different in shape and coverage of the feature 
space.  
Complete pairwise comparison results of the 6 CP4-shifted samples are 
shown in Figure 21F. With respect to relative shifts of 0 or 1 IQR units, CP4s are 
more similar to themselves than to the other cell populations. The 3-unit shift CP4 
is more similar to the 2-unit shift CP4, and the 4-unit shift CP4 is more similar to 
the 3-unit shift and 5-unit shift CP4, etc. We computed the p-values of the FR 
statistic for the mapping of each cell population to its original parent cell 
population under shifts in marker expression levels. The cutoff for p-value was 
fixed at 10-7 across all three simulation cases. -log10 p-values of the FR statistics 
increase linearly as the shift in marker position increases. Based on these results, 
using a p-value threshold of 10-7 would general provide robust mapping of 
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populations with slight shifts (<1 IQR) in the expression of one of the cell surface 
markers between samples. 
Matching with over-partitioning of cell populations in some samples. 
During cell population identification, certain cell populations might be 
inappropriately divided into two (over-partitioning) depending on the method and 
configuration parameters used, even though there is no real evidence that the two 
partitions correspond to distinct cell populations.  In order to determine how 
FlowMap-FR would handle over-and under-partitioning, we artificially partitioned 
each of the nine cell populations above and below a range of selected percentiles 
along the CD23 expression level axis. A total of 18 test samples were generated for 
each cell population, consisting of its corresponding partitions (9 samples each for 
partitions above and below the percentile cutoffs, from 10% to 90%; see Methods 
for details); the other cell populations remained unchanged.  
Figure 22A - I shows the mapping results of the nine cell populations. In Figure 
22A, the two sets of estimated FR statistics computed when mapping the two 
partitioned CP1s in the test sample to the unchanged CP1 in the reference sample 
are significantly larger than those obtained in comparison with the other cell 
populations. The test correctly mapped both partitioned cell populations to the 
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unchanged reference cell population across varying partitions. Results also show 
FR statistics increases when the partition size increases, so the two lines of FR-
statistics representing the two partitions cross as one partition increases size and 
the other decreases size. That the two lines are not completely symmetric is due to 
the non-symmetric distribution of skew-t data simulation. The same pattern is 
found for the other eight cell populations in Figures 5B – I. Therefore, FlowMap-
FR is able to quantify similarity of inappropriately partitioned subpopulations with 
the original cell population in the reference sample and could therefore be used to 
detect and correct over-partitioning that could arise from manual gating or 
algorithmic clustering. We also computed the p-values of the FR statistics for each 
cell population comparison. Similar to the results of FR statistics, selecting a p-
value threshold of ~10-7 distinguishes between correctly matched and incorrectly 
matched population partitions. Figure 22J displays the complete pairwise 
comparisons of CP5 partitions above cutoffs along CD23 expression levels with 
itself and other cell populations. From this heat map, it is clear that all 10 
partitions of CP5 are more similar to the unpartitioned CP5 in the reference 
sample based on the FR statistic since all of the squares in the central CP5 vs. 
CP5 box have a higher FR statistic (more blue) than any other comparisons of cell 
populations against CP5. 
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Matching populations using the symmetric KL divergence (SKL) measure 
Figure 23A - I shows the results of matching CP1, CP2, and CP3 with all 
other cell populations using the SKL distance under scenarios in which differences 
in cell proportions occur between biological samples (A - C) and under scenarios in 
which a discrete cell population in one biological sample was inappropriately 
divided into two by over-partitioning of the data from another biological sample (D 
- I). Under the scenario in which differences in cell proportions occur between 
biological samples, the SKL distance value is always close to zero when matching 
cell populations of varying proportions in the test sample to corresponding cell 
populations in the reference sample. However, the differences between the SKL 
distance values of equivalent and nonequivalent cell populations are not as large as 
those between the FR statistics (compare Figure 23 A – C with Figure 20). Thus, 
it could be difficult to use the SKL distance value to distinguish mapping from 
non-mapping cases. In theory, the SKL distance could be used for population 
mapping by choosing the best matched cell population. But if the cell population 
to be mapped does not occur in the test sample, mapping to the best matched 
population without considering the similarity value would give an incorrect result. 
Similar phenomena were found under scenarios in which a cell population is 
inappropriately divided into two by over-partitioning (Figure 21D – I). The SKL 
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distance performs poorly when comparing CP1 partitions below 10th, 20th, and 
30th percentiles in the test sample with CP1 in the reference sample (Figure 23D 
and G). In fact, the SKL distance values are smaller when comparing these CP1 
partitions to CP4 in the reference sample than when comparing to the reference 
CP1.  
For scenarios in which cell populations are shifted in marker expression 
levels, the SKL distance performs in a similar way to the FR statistics, i.e. linearly 
changing values with increasing shifts.  
4.4.2 Mapping cell populations across multiple samples in real data 
Real FCM data set #1 
Figure 24A – B shows the results of matching cell populations across four 
real FCM samples using the FR-based distance measure. Samples 1 and 2 are the 
biological replicates of the blood sample from the first subject, and Samples 3 and 
4 are biological replicates of the blood sample from the second subject. In Figure 
24A, the FR-based distance measure (-1*FR statistic) was computed for each cell 
population pairwise comparison and displayed in a heatmap. The blocks colored in 
blue suggest matched population pairs, and the blocks colored in red suggest 
mismatched population pairs. We employed hierarchical clustering method with 
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complete linkage to match cell populations across samples, using the FR-based 
dissimilarity measure as the distance metric. The cell populations were grouped 
into four sets of equivalent cell populations. For example, in the first set of 
matched cell populations, CP1.2 (Sample 1, CP 2), CP2.4 (Sample 2, CP4), CP4.3 
(Sample 4, CP3) and CP3.4 (Sample 3, CP4) were grouped and matched to each 
other. CP1.2 and CP2.4 belong to biological replicates of one blood sample, while 
CP4.3 and CP3.4 belong to biological replicates of the other blood sample. In the 
hierarchical relationship of the cell populations across samples, CP1.2 is more 
similar to CP2.4 than to CP4.3 or to CP3.4. We observed the same relationship in 
each set of equivalent cell populations, namely that cell populations belonging to 
the biological replicates of the same sample are more similar to each other. Similar 
to the results of FR statistics, selecting a p-value threshold of ~10-7 also 
distinguishes between correctly matched and incorrectly matched populations. We 
also performed cell population mapping using flowMatch with the FR-based 
distance measure and using flowMatch with symmetric KL divergence (SKL) as 
the distance measure. Both versions of flowMatch generated the same cell 
population mapping results as show in Figure 24A. In Figure 24B, the hierarchical 
relationship between the samples were computed using flowMatch with the FR-
based distance measure. In both versions of flowMatch, biological replicates of the 
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same blood sample are matched and more similar to each other than the FCM 
samples that come from different subjects.  




Figure 25 shows the results of matching cell populations across thirty real 
FCM samples using the FR-based distance measure. The FR-based distance 
measure was computed for each cell population pair comparison and displayed in a 
heatmap. The blue blocks with large FR-based distance (low FR statistic values) 
suggest matched population pairs, and the red blocks with small FR-based distance 
(high FR statistic values) suggest mismatched population pairs. The cell 
populations are arranged in a hierarchy based on the FR similarity to all other cell 
populations. The cell populations were then grouped according to their FR distance 
as reflected in the structure of the hierarchical clustering tree to generate eight sets 
of equivalent cell populations. F-measures were computed to evaluate the combined 
precision and recall of the FlowMap-FR classification method. We obtained an 
overall F-measure of 0.88, which indicates high agreement between manual 
gating/mapping and the cell population mapping derived from the FR-based 






Mapping of equivalent cell populations across different samples is an 
essential component of comparative analysis pipelines for cell-based 
immunoprofiling and biomarker discovery in biomedical research to monitor disease 
progression and treatment responses. However, the ability to precisely match cell 
populations is complicated by natural and technical contributions to variation in 
marker expression values and their distributions. FlowMap-FR directly addresses 
the cell population mapping challenges that may arise during the FCM data 
processing workflow without a priori assumptions about the marker expression 
distributions in the different cell populations analyzed, and thus can be readily 
employed in comparison of skewed, non-parametric, and multi-modal distributions. 
The method is highly robust, as illustrated in matching cell populations of varying 
shapes, locations, and correlations between marker features under scenarios of 
differences in population proportions between samples and modest shifts in marker 
distributions. Because FlowMap-FR is a stand-alone cell population mapping 
method, it can be incorporated into any FCM analytical workflow that requires a 
cell population-matching step.  
The mapping approach in FlowMap-FR provides a similarity measure of cell 
populations under various sample variation scenarios. This similarity measure can 
be converted into a probability measure assuming that the statistic follows a 
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normal distribution 88. The statistic is an objective measure of similarity between 
data distributions, with values closer to zero reflecting similar data distributions 
(more precisely, that the two “samples” are derived from a single underlying global 
data distribution) and values approaching large negative values reflecting different 
data distributions (that the two “samples” are derived from different underlying 
global data distributions). However, the choice of whether two cell populations are 
“equivalent” is somewhat subjective and specific to the experiment in question. To 
deal with this experiment-specific decision, it is possible to choose a threshold for 
the statistical value across the comparison pairs to distinguish equivalent 
(matched) versus distinct (mismatched) cell populations. We have observed larger 
gaps in the FR statistic values for threshold selection compared with other existing 
methods, such as the SKL distance. When cell population marker distributions 
were similar between samples there was an obvious gap in the FR statistic values 
between matched versus mismatched cell population pairs such that the threshold 
was relatively easy to identify. Alternatively, an agglomerative clustering method, 
such as hierarchical clustering, could be applied to identify groupings of cell 
populations with similar expression profiles. 
One challenging population mapping scenario occurs when one sample 
contains a cell population that is absent from another sample, as might occur when 
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a novel abnormal cell population arises in a particular disease setting. We found 
that when there were different numbers of cell populations between the test and 
reference samples, judicious selection of an FR statistic threshold could reveal the 
presence of a distinct cell population in one sample that was absent from the other. 
However, the selection of this threshold could be challenging in some cases. In this 
scenario, the ideal reference sample for comparison would be one that contains the 
union of all cell populations found in each of the individual test samples. This 
composite sample could be generated by concatenating the data from multiple FCS 
files and running the population identification methods on the concatenated file to 
identify all cell populations present in each of the individual samples. This 
composite sample could then be used as a reference for comparison and mapping. 
While FlowMap-FR was relatively robust to moderate shifts in marker 
expression (<1 IQR) that could result from natural biological variability or 
differences in staining protocols/reagents and instrument configuration settings 
between experiments and labs, we expect that its performance could be enhanced 
further by applying a sample alignment procedure to the data before the 
population mapping step in the FCM data processing workflow. Cell populations 
observed can be similar in shape and relative location in each sample but different 
in absolute marker expression levels across samples. Marker expression levels can 
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be normalized across samples on a per-channel basis 98 before cell population 
mapping to further improve the results. Many software and computer programs are 
available for this data transformation purpose, such as flowTrans 86, FCSTrans 
(the method used in this paper 95), FCS2CSV 99, etc., before mapping cell 
populations in FlowMap-FR. 
However, in some experimental scenarios marker expression shifts reflect 
important phenotypic changes in the cell population of interest, for example when 
activation marker expression increases in response to cell stimulation. As a 
statistical test, FlowMap-FR can be used to determine when the expression of a 
cellular marker has become significantly different from a comparison population 
(e.g., using FR values from known different cell types in control samples to 
determine thresholds). Although the FR statistic cannot determine whether one 
cell population is functionally different from the other, it provides an objective 
measure for scientists to identify candidate phenotypes for biological interpretation 
and validation. 
FlowMap-FR was also found to be able to map cell populations that are 
inappropriately partitioned in a subset of samples. We observed that across varying 
partitions of cell populations in different samples, FlowMap-FR correctly mapped 
the partitions to the original cell populations in the reference sample and ranked 
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the partitions by degree of overlap with respect to the original cell population. The 
over- or under-partitioning of cell populations is a common artifact in many 
automatic gating methods. Thus, the FR statistic can also serve as a tuning metric 
for parameter adjustment during the automated gating process to prevent artificial 
population splitting or simply as a quality control metric on the gated samples. 
Computational efficiency is a major consideration in the analytical workflow 
of FCM data processing because of the increasingly large quantities of samples, 
events and markers being evaluated. The bottleneck of FlowMap-FR computations 
lies in finding the minimum spanning tree (MST) in order to compute the FR 
statistic. We used Prim’s algorithm to compute the MST, in which the 
computational complexity increases quadratically in the number of nodes, i.e., the 
number of events in the graph. To circumvent the runtime limitation, we 
implemented a controlled random sampling procedure to estimate the FR statistic 
for each cell population pair comparison. The random sample procedure achieved 
good precision and accuracy in estimating the true FR statistic. Moreover, we 
parallelized the estimation procedure so that the users may choose to perform the 
analysis on as many cores as their computing environment allows. For a single cell 
population comparison in FCM samples with four feature markers, the runtime on 
a 10 core system is ~10 times faster than the run time on a single core system. In 
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the future, the runtime can be further improved by parallelizing the sequential 
computations of multiple sample comparison of cell populations.  
We have implemented FlowMap-FR in R as a Bioconductor package 
(http://www.bioconductor.org/packages/devel/bioc/html/flowMap.html). We are 
also in the process of implementing and incorporating FlowMap-FR into the 
GenePattern FCM suite 100 and the bioKepler workflow platform 101 so that it can 
be used along with other FCM data processing and analytical methods that have 
been deployed in these platforms. A common FCM computational workflow 
consists of four steps: data transformation and preprocessing, computational 
identification of cell populations, sample alignment, and cross-sample comparison 
of cell populations. While there have been a large number of methods developed for 
the transformation and identification steps, only a few methods are available for 
the sample alignment and cross-sample comparison steps. FlowMap-FR provides a 
robust non-parametric probability-based solution to these workflows, facilitating 
the move towards the next paradigm for result interpretation across samples and 












Figure 18. Multivariate run calculation. 
This figure illustrates the general problem of mapping cell populations between 
samples using FCM data with four marker channels (CD4, CD45RA, ZAP70, and 
SLP76). In this example, we want to determine if Cell Population (CP)red in or 
CPgreen in Sample B corresponds to CPblue in Sample A. (A) Marker level 
distributions of CPblue in comparison with CPred and CPgreen. Note that the 
marker level distributions for CPblue and CPgreen are similar for ZAP70 and 
SLP76, but differ for CD4. Based on this difference we would infer that CPgreen in 
Sample B is different from CPblue in Sample A. On the other hand, the marker 
expression distributions for CPblue and CPred are similar for all four markers. 
Based on these similarities we would infer that CPred in Sample B is equivalent to 
CPblue in Sample A. (B) Multivariate run calculation for the CPblue/CPred and 
CPblue/CPgreen comparisons. The FlowMap-FR application of the Friedman-
Rafsky test proceeds through the following steps separately for CPblue/CPred and 
CPblue/CPgreen comparisons: merge the cell event data from the reference 
(CPblue) and test (CPred or CPgreen) populations, calculate the pairwise 
Euclidean distances between all events (nodes) to form a complete Euclidean 
graph, find the minimum spanning tree that connects all nodes in the Euclidean 
graph, remove edges that connect nodes derived from different cell populations, 
and determine the number of subgraphs remaining (which equals the number of 
edges connecting nodes  between the two different cell populations plus 1). In the 
case of the CPblue versus CPgreen comparison, the number of runs would equal 2. 
For the CPblue versus CPgreen comparison, the number of runs would equal 25. 
Relatively small run values indicate that the cell populations being compared are 










Figure 19. Data simulations and test scenarios. 
(A) Selected bi-axial plots of the 9 cell populations from an experimentally 
measured data set in four marker channels (CD14, CD23, CD3, CD19). For each 
population, multivariate skew-t distributions were fitted and the corresponding 
distribution parameters determined. (B) Selected bi-axial plots of the 9 cell 
populations in the simulated data set. The skew-t distribution parameters derived 
from fitting the original data were used to simulate the nine populations shown. 
The simulated cell populations mimic the original cell population in the correlation 
between markers and also the marker distributions. These parameters were 
employed to simulate cell populations throughout the current study. (C) Scenario 1 
- Differences in cell populations between samples. Overlap between CP4 changed in 
proportion to 1%, 10%, 25%, and 50% (colored in green) and the original 2363 
events in population CP4 in the reference population (colored in cyan). Scenario 2, 
in which the test cell population was deleted, is not shown but would essentially 
correspond to the first plot without the green events. (D) Scenario 3 - Shifts in 
marker expression levels between samples. CP1 (colored in blue) shifted along 
CD19 to 2, 3, 4, and 5 units of interquartile range (IQR) of the CD19 distribution. 
(E) Scenario 4 - A discrete cell population in one sample inappropriately divided 
into two by over-partitioning in another sample. The original CP4 (colored in 
cyan) overlaid with the CP4 partitions below CD23 10th, 30th, 70th, and 90th 











Figure 20. Matching cell populations that differ in proportions between samples. 
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FR statistics comparing each simulated cell population CP1 – CP9 (A – I, 
respectively) under varied proportions (1%, 10%, 25%, 50%, 75%, 100%, 125% and 
150% of the original cell count) with all cell populations in the reference sample 
containing 100% of all cell events. In all 9 sets of analyses, the FR statistic is larger 
when comparing a changed cell population to the original cell population than 
when comparing it to the other cell populations across varying proportions of 
original cell counts. In other words, the changed cell population in the test sample 
can be determined to be most similar to the corresponding population in the 
reference sample based on the largest FR statistic value in a comparison against all 
nine populations in the reference sample. (J) Heat map for comparing all cell 
populations between the test samples (Sample Set A) and the reference samples 
(Sample Set B). We CP5 and changed its proportions in different test samples. 
The rows and columns are ordered by cell population IDs (CP1-CP9) and then by 
population proportion ID (1-8, with 1 being 1% and 8 being 150%). Squares 
colored in blue are the highly similar cell population pairs with an FR statistic 
close to 0, while yellow, orange and red squares are more dissimilar pairs with 
negative FR statistics. The regions of the heat map that correspond to the 










Figure 21. Matching cell populations with shifted marker distributions between 
samples. 
Shifted CP4 populations compared to the original CP4 (A) and other unchanged 
cell populations (B – E). The amount of shifting is quantified as units of the 
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calculated interquartile range (IQR) in each of the respective marker distributions 
(CD3, CD14, CD19, and CD23). The left-most column displays the FR statistics 
for the five sets of population comparisons with CP4 shifts of 0, 1, 2, 3, 4, and 5 
IQR units of the corresponding original marker distribution in the indicated 
dimension. In (A), the shifted CP4 is compared to itself. As the amount of shifting 
increases, the dissimilarity grows between the changed CP4 and the original CP4 
as indicated by the increasingly negative FR statistic in the left hand graph. The 
FR statistics are similar along the four marker distributions. The red line 
highlights the comparisons with the most pronounced FR statistics change over 
IQR shifts. For example, in (E), the red line corresponds to the FR statistics for 
comparing shifted CP4 along the CD3 axis against CP7, and the three black lines 
correspond to the comparisons of CP4 against CP7 along the CD23, CD19, and 
CD14 axis. The dot plots shown to the right illustrate locations of CP7 and the 
shifted CP4 along the CD3 axis. (F) Heat map for comparing all cell populations 
between the test samples (Sample Set A) and the reference samples (Sample Set 
B). We chose CP4 and shifted it along the CD19 axis in the test samples. The 
rows and columns are ordered by cell population IDs (CP1-9) and then by 
population shift ID (1-6, with 1 being no shift and 6 being a 5*IQR shift). Squares 
colored in blue are the highly similar cell population pairs with an FR statistic 
close to 0, while yellow, orange and red squares are more dissimilar pairs with 
negative FR statistics. The regions of the heat map that correspond to the 











Figure 22. Matching cell populations inappropriately divided into two populations 
in one sample. 
(A – I) FR statistics comparing the two partitioned cell populations in the test 
sample to all (intact) cell populations in the reference sample. The two partitioned 
populations are generated by dividing the indicated cell population with a discrete 
value for CD23 marker expression so that the two partitioned populations are 
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above and below the 10, 20, 30, 40, 50, 60, 70, 80, and 90th percentile in the CD23 
marker distribution. Across the analyses, the two intersecting lines seen at the top 
of each graph show that the FR statistics are always the largest when the two 
partitioned populations in the test sample are compared to the intact parent cell 
population in the reference sample. (J) Heat map for comparing all cell populations 
between the test samples (Sample Set A) and the reference samples (Sample Set 
B). We chose CP5 to partition and compared the 10 testing samples with different 
CP5 upper partitions along the CD23 axis with the intact CP5 in the reference 
samples. The rows and columns are ordered by cell population IDs (CP1-9) and 
then by partition ID (1-10, with 1 being 10th percentile and 10 being no partition). 
Squares colored in blue are the highly similar cell population pairs with an FR 
statistic close to 0, while yellow, orange, and red squares are more dissimilar pairs 








Figure 23. Matching cell populations using SKL divergence measure. 
 
 138 
(A – C) SKL distance values (y-axis) from comparing CP1, CP2 and CP3 to all 
reference cell populations under varied proportions (x-axis showing 1%, 10%, 25%, 
50%, 75%, 100%, 125% and 150% of the original cell counts of CP1-3, compared 
against reference cell populations with 100% of their cell events). For example, in 
(A), each line records the eight SKL distance values generated from comparing 
eight different proportions of CP1 to each of the original cell populations, including 
itself. (D - I) The SKL distance of comparing two partitions of a cell population 
(CP1-3) to all reference cell populations, including itself. D - F display SKL results 
in complete value ranges. G - I zoom in and show the top region of the D - F 








Figure 24. Matching cell populations across the real FCM data set #1. 
(A) Heatmap of the FR distances (-1*FR statistics) for comparing all cell 
populations across four real flow cytometry samples. The cell populations in the 
samples were identified using K-means clustering with possible number of cell 
populations ranging from 4 to 20. The FR statistics were computed for all possible 
pairwise comparison of the cell populations. We computed a dissimilarity measure 
based on the FR statistic (-1*FR) and employed the FR-based distance measure to 
organize the cell populations using hierarchical clustering with complete linkage. 
(B) flowMatch results of matching FCM samples using the FR distance as the 
dissimilarity metric between cell populations across samples. The distance between 
FCM samples was computed based on the weighted sum of distance between cell 
populations across samples. y-axis represents the FR-based metric (-1*FR) between 
individual FCM samples. These results are the same as Figure 24A, where distance 
measure was only computed at the population level, and also the same as when 
applying the default flowMatch method with symmetric KL divergence measure as 







Figure 25. Matching cell populations across the real FCM data set #2. 
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Heatmap of the FR distance (-1*FR) for clustering all cell populations across thirty 
real flow cytometry samples in the real FCM data set #2. The FR statistics were 
computed for all 28,680 possible pairwise cell population comparisons. We 
multiplied the FR statistics by -1 to obtain a dissimilarity measure. Blue boxes in 
the dissimilarity heatmap correspond to similar population pairs with small FR 
distance (large FR statistic); red box correspond to population pairs that are not 
similar to each other with large FR distance (small FR statistic). Each sample had 
8 cell populations delineated by expert manual gating as part of the FlowCAP-I 
challenge. Cell populations are organized according to the value of the FR distance 
using hierarchical clustering with complete linkage. The green boxes on the plot 
delineate the eight cell populations deemed equivalent to each other across the 
thirty FCM samples in the experiment based on FR distance as reflected in the 





Multivariate statistics provide a convenient framework for integrating layers 
of genetic information in the analysis of high-throughout biological assays. This 
dissertation introduces multivariate statistical methods for the analysis of ribosome 
footpring profiling data and flow cytometry data.  
Chapter 2 presents pairedSeq, an empirical covariance shrinkage method for 
differential testing of translation efficiency from sequencing data. The method 
explicitly models co-variability in ribosome occupancy and transcript abundance, a 
source of variation that directly affects the dynamic range of expression 
measurements in the analysis of translation efficiency. Results indicate that 
pairedSeq effectively shrinks covariance estimates and is able to identify differences 
in translation efficiency in samples with high measurement variability. 
Chapter 3 surveys the contribution of translational regulation in gene 
expression level differences between human and chimpanzee. Through joint analysis 
of ribosome footprint profiling data with RNA-seq measurement of transcript levels 
and quantitative mass spectrometry measurement of protein levels, we provided 
the first integrative view on gene express variations across primates that allows a 
separation between translational and post translational events. We found extensive 
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post translational buffering of gene expression variations that lead to a stable 
protein level across primate species. We propose a scenario where buffering evolved 
under stabilizing selection of protein levels that removes negative effects on 
organismal fitness from protein level variations and allows the transcript level to 
diverge for quick adaptation to environmental changes.  
Chapter 4 describes FlowMap-FR, a statistical method developed to 
compare and match cell populations homogeneous in protein expression profiles in 
flow cytometry data. FlowMap-FR directly addresses the cell population mapping 
challenges that may arise during the FCM data processing workflow without a 
priori assumptions about the marker expression distributions in the different cell 
populations analyzed, and thus can be readily employed in comparison of skewed, 
non-parametric, and multi-modal distributions. The method is highly robust, as 
illustrated in matching cell populations of varying shapes, locations, and 
correlations between marker features under scenarios of differences in population 
proportions between samples and modest shifts in marker distributions. Because 
FlowMap-FR is a stand-alone cell population mapping method, it can be 
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